ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[FASLG, PRL, HHEX, STAB1, EMILIN1, HOXA5, CCR2, HSPG2, DCN, HGS, CX3CR1, THBS1, E2F2, TGFB2, PLK2, TIE1, CXCL10, TEK, PF4]
GO:0036376;sodium ion export across plasma membrane;9.0;1.0;0.896240625180289;9.628524252492122;131.16583792001737;7.138016298065211;0.004390002553592762;0.7612791106150483;[ATP1B2, ATP1B1, SLC8A1]
GO:1900016;negative regulation of cytokine production involved in inflammatory response;8.0;1.0;0.875;9.628524252492122;227.00494280179373;7.379178354882098;0.007597651144391222;0.7523715242355574;[IL1R2]
GO:0002001;renin secretion into blood stream;9.0;1.0;0.896240625180289;9.628524252492122;133.331941423656;9.083926447120524;0.004462500088492957;0.8607930461318132;[SUCNR1]
GO:0071380;cellular response to prostaglandin E stimulus;8.0;1.0;0.875;9.628524252492122;704.3614414198233;6.943860283624253;0.023574343560179453;0.7301093378270707;[P2RY6, PTGER2, AKT1, PTGDR]
GO:0003333;amino acid transmembrane transport;9.0;0.5756379274792419;0.68405958891991;8.302854513188667;195.84914281057607;5.500407508664414;0.006554894557084751;0.6775317209684948;[SLC43A2, SLC1A3, SLC3A1, SLC38A11, SLC7A11, SLC1A6, SLC38A6, SLC17A6, SLC36A1, SLC38A1, SLC6A16, SLC6A15, SLC6A6, SLC7A5, SLC7A7, SLC7A8]
GO:0002003;angiotensin maturation;8.0;1.0;0.875;9.628524252492122;184.72117518317427;7.379178354882098;0.00618245149511628;0.7523715242355574;[ENPEP, ACE, MME, CTSZ, CTSG]
GO:0000186;activation of MAPKK activity;13.0;0.8259837884571596;0.8755468589962163;9.54300207905396;3706.2450018205795;5.845247994956144;0.12404468480698592;0.7614812190615239;[LRRK2, EGF, F2R, ADAM9]
GO:0050435;amyloid-beta metabolic process;6.0;0.9326813400603323;0.7894609826203107;9.533214072687796;60.01596331221528;6.943860283624253;0.0020086802811995464;0.6782296504172152;[ACE, MME, PSEN2, APEH]
GO:0036006;cellular response to macrophage colony-stimulating factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;8.16763571524637;0.0027327542132076126;0.7408135829017477;[CSF1R]
GO:0036486;ventral trunk neural crest cell migration;8.0;1.0;0.875;9.628524252492122;24.653414450138296;8.67846133901236;8.251275950136018E-4;0.8188169164668168;[NRP1]
GO:0061444;endocardial cushion cell development;5.0;1.0;0.7902410118609202;9.628524252492122;34.232648149996464;9.777073627680469;0.0011457359261972313;0.7902410118609202;[JAG1]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[NRP1, HCK, NTF3, STAP1, TEK]
GO:1900025;negative regulation of substrate adhesion-dependent cell spreading;8.0;1.0;0.875;9.628524252492122;367.370684139938;7.212124270218933;0.012295566186013157;0.7438283705770736;[TACSTD2, FBLN1, ACTN4]
GO:0048009;insulin-like growth factor receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;7.138016298065211;0.0010376185600805164;0.7400384854347593;[GHR, CRIM1, AKT1, TSC2]
GO:0048008;platelet-derived growth factor receptor signaling pathway;8.0;0.7763722522362496;0.7631861261181248;9.186691500213083;31.002284443533863;6.280566066213989;0.0010376185600805164;0.6961884407023742;[PDGFRB, NRP1, PDGFRA, NR4A3, PDGFD, PDGFC]
GO:1900026;positive regulation of substrate adhesion-dependent cell spreading;8.0;1.0;0.875;9.628524252492122;350.51777089970517;6.280566066213989;0.011731514346499779;0.6961884407023742;[DOCK5, NRP1, OLFM4, DNM2, FLNA]
GO:0003222;ventricular trabecula myocardium morphogenesis;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;28.30750056401912;7.004484905440688;9.474265687811956E-4;0.7091290490632969;[TGFB2, ENG]
GO:1900028;negative regulation of ruffle assembly;9.0;1.0;0.896240625180289;9.628524252492122;173.84791521056468;8.16763571524637;0.005818533269131697;0.8139338954918922;[TACSTD2, STAP1]
GO:0048012;hepatocyte growth factor receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;7.292166977892469;0.0010376185600805164;0.747921758369865;[NRP1, PAK1, STMN1]
GO:0048010;vascular endothelial growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.186691500213083;31.002284443533863;5.572381008289503;0.0010376185600805164;0.6599718239061428;[CYFIP1, NRP1, NRP2, ITGB3, NCF4, VAV1, NCKAP1L, FYN, MAPK14, PTK2]
GO:0051894;positive regulation of focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;280.4986055833795;6.599019797332524;0.009388035896519984;0.712474179321389;[NRP1, EPB41L5, TEK]
GO:0070392;detection of lipoteichoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;133.13119460921556;9.777073627680469;0.0044557812732740395;0.8231203125901445;[TREM2]
GO:0048015;phosphatidylinositol-mediated signaling;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;5.649939242635378;8.845336528452411E-4;0.6398575208746181;[CSF1R, PTAFR, GATA3, AKT1, KCNH1, PDGFRB, PDGFRA, GSN]
GO:0070278;extracellular matrix constituent secretion;6.0;0.8653626801206646;0.7558016526504768;9.377209824211215;23.0991473088411;8.67846133901236;7.731076725439974E-4;0.7669372290569613;[ENG, CTGF]
GO:2000249;regulation of actin cytoskeleton reorganization;8.0;0.8933024483968273;0.8216512241984136;9.427853557029971;36.19570401534177;6.221725566191056;0.0012114376393747596;0.6931793347948383;[NRP1, PDGFRA, CSF1R, TGFB1, F11R, HCK, ARHGDIA, NTF3, ARHGDIB, STAP1, TEK]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CD80, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, GAB1, VAV1, EREG, BTC, LCK, KIT, CHI3L1, HBEGF, ENG, GATA3, THBS1, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK]
GO:0060385;axonogenesis involved in innervation;9.0;1.0;0.896240625180289;9.628524252492122;65.99544162831262;8.16763571524637;0.0022088080392582156;0.8139338954918922;[NRP1]
GO:1902336;positive regulation of retinal ganglion cell axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;1458.3969986044274;9.083926447120524;0.04881123507120434;0.9126727335416687;[NRP1]
GO:0150020;basal dendrite arborization;10.0;1.0;0.9152410118609203;9.628524252492122;197.41096074002914;8.67846133901236;0.006607167197638665;0.8590579283277371;[NRP1]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[CLEC10A, ICAM2, PAK1, KLRK1, FYN, MUC15, PRKACB, LYN, FCER1G, CHUK, SYK, CARD9, NFKB1, CLEC4D, CARD11]
GO:0002455;humoral immune response mediated by circulating immunoglobulin;7.0;1.0;0.8509193652572005;9.628524252492122;48.293467131004675;8.390779266560578;0.001616338883576055;0.7800242071602487;[EXO1, HLA-DQB1]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, ECM1, SERPINA1, PROS1, ITGB3, ITGA2B, F13A1, LAMP2, TIMP3, CD36, TIMP1, VWF, ACTN1, ANXA5, ACTN4, F5, PECAM1, TLN1, VCL, STXBP2, THBS1, PSAP, FLNA, LYN, TGFB2, TGFB1, EGF, PCDH7, LHFPL2, PPBP, CD9, PF4]
GO:0006814;sodium ion transport;7.0;0.811012628672052;0.7564256795932265;9.310070521373587;34.16983994150393;4.629579150867016;0.001143633791982704;0.5876762583299873;[SLC8A1, SCN1A, SLC13A1, SLC38A1, SLC6A16, SLC6A15, SLC6A13, ATP1B2, ATP1B1, SLC5A7, SGK1, CAPS2, SLC22A4, SLC24A2, SLC24A1, SLC24A4, SLC38A11, SLC5A4, SLC38A6, SLC17A6, SCN3A, SLC17A3, SLC12A2, SLC10A2, SLC12A1, SLC4A7, SLC6A6]
GO:0002456;T cell mediated immunity;5.0;0.7586651285174919;0.6695735761196662;9.117698628726131;29.48574010893193;6.250713103064308;9.868611860026806E-4;0.609902770639515;[DENND1B, JAG1, SLC11A1, GATA3, IL18RAP, CTSH]
GO:0098712;L-glutamate import across plasma membrane;12.0;0.9326813400603323;0.9144609826203107;9.600353375525426;1074.08790550917;7.9853141584524145;0.03594875558103501;0.8564896500084854;[SLC1A3, SLC1A6]
GO:0006816;calcium ion transport;8.0;0.6696747006330769;0.7098373503165385;8.690254613899192;35.67391733828006;4.3132418226548594;0.001193973908871026;0.5955793873968269;[DENND5B, PHB2, SLC8A1, CTGF, F2R, CACNA2D3, CALCRL, CUL5, PSEN2, CACNA1F, CORO1A, CCR1, CAV1, BSPRY, PTPRC, ATP2A3, FASLG, JPH2, CCR7, CCR5, TRPC7, TRPC3, TRPC1, TMEM37, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, ATP2C2, CCL8, PLN, CCL5, NPY, FYN, CCL19, CCL21, RAMP1]
GO:2000134;negative regulation of G1/S transition of mitotic cell cycle;9.0;0.7980440201809971;0.7952626352707877;9.394909401310617;355.88113835876356;5.244474134527214;0.011911021428637128;0.6644432763129993;[CDKN1A, SOX4, PCNA, GPNMB, NACC2, E2F1, CCL2, SFN, E2F7, PLK2, CNOT3, EZH2]
GO:0051549;positive regulation of keratinocyte migration;9.0;1.0;0.896240625180289;9.628524252492122;297.9389118084288;7.697632086000634;0.009971747250615804;0.7898978880348613;[ADAM9, MMP9, HBEGF]
GO:2000391;positive regulation of neutrophil extravasation;10.0;1.0;0.9152410118609203;9.628524252492122;703.074040491935;8.16763571524637;0.023531255409708643;0.8329342821725234;[IL1R1]
GO:0033077;T cell differentiation in thymus;7.0;0.8653626801206646;0.7836007053175329;9.420884887713877;66.99450330244977;6.481236761676141;0.002242245734394454;0.6823701146576509;[BCL11B, FZD5, DNAJA3, CCR6]
GO:1904886;beta-catenin destruction complex disassembly;5.0;1.0;0.7902410118609202;9.628524252492122;38.04764185170599;6.7325511899570465;0.0012734203321220245;0.6345439928109722;[FZD1, FZD5, CAV1, PPP1CA]
GO:1901018;positive regulation of potassium ion transmembrane transporter activity;10.0;0.7671156992804218;0.7987988615011312;9.418803721510052;727.157729141708;6.7325511899570465;0.02433731479490395;0.7595439928109722;[ATP1B2, ATP1B1, DNM2]
GO:0002588;positive regulation of antigen processing and presentation of peptide antigen via MHC class II;7.0;1.0;0.8509193652572005;9.628524252492122;143.84822124462497;9.083926447120524;0.004814470510063408;0.8154717862087246;[PYCARD, TREM2]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, CHEK1, AKT1, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:0006702;androgen biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;272.3789533364416;7.379178354882098;0.00911627844302757;0.728290889492758;[SRD5A3]
GO:0030913;paranodal junction assembly;6.0;1.0;0.8231203125901445;9.628524252492122;88.99224575364705;7.8311634786251565;0.00297849037755313;0.7236063770733796;[CD9]
GO:0140009;L-aspartate import across plasma membrane;12.0;1.0;0.9481203125901445;9.628524252492122;681.8170375248549;9.083926447120524;0.022819802650461112;0.9126727335416687;[SLC1A3]
GO:2000146;negative regulation of cell motility;6.0;0.5781283279524737;0.6121844765663813;8.01908634005802;116.39406446339459;4.247644540169047;0.0038956045897326065;0.5403450519100613;[SPINT2, CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, TPM1, MIF, SFRP2, PADI2, VCL, TACSTD2, FBLN1, GATA3, KLRK1, STAP1, TGFB1, JAG1, JUP, CXCL12, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, TMEFF2, ENG, CX3CR1, LRP1, THBS1, SPOCK3, CCL2, CCL21, TIE1, PODN]
GO:2001237;negative regulation of extrinsic apoptotic signaling pathway;9.0;0.8436909121759173;0.8180860812682478;9.50592193039979;358.6811287979994;5.152100814396198;0.012004734588810557;0.6597193004257005;[NRP1, HMGB2, TNFAIP3, FASLG, BRCA1, TNF, LGALS3, AKT1, SFRP2, IL1B, CX3CR1, YAP1, IFI6, THBS1, FYN, TNFRSF10B, PF4]
GO:0002281;macrophage activation involved in immune response;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;81.79914540449643;7.379178354882098;0.0027377437822370863;0.7004918368257019;[CX3CR1, SUCNR1, SYK, HAVCR2]
GO:0006883;cellular sodium ion homeostasis;9.0;1.0;0.896240625180289;9.628524252492122;285.76071857591336;6.8867018697843045;0.009564154082785858;0.7484268790654467;[ATP1B2, ATP1B1, SLC8A1]
GO:0006520;cellular amino acid metabolic process;6.0;0.406884124246779;0.526562374713534;6.526182243879872;77.81072980309767;4.002522082136061;0.0026042551013992716;0.5278094780068945;[CPOX, MCCC2, KMO, MTHFD1, PADI4, GMPS, SLC1A3, GLYAT, ACMSD, AGXT2, SLC6A6, HAL, ALDH6A1, P4HA2, NOX4, ALDH18A1, SERINC5, HIBADH, PFAS, GHR, HIBCH, ARG1, PRODH2, SLC7A5, SLC7A7, SLC7A8, DPYD, SLC3A1]
GO:0002042;cell migration involved in sprouting angiogenesis;9.0;1.0;0.896240625180289;9.628524252492122;27.169092758590633;7.069023426578259;9.093250840340128E-4;0.757750811958709;[NR4A1, NRP1, EGR3]
GO:0002286;T cell activation involved in immune response;6.0;0.6997970393407541;0.6730188322605215;8.890925309361343;82.05045983278045;5.845247994956144;0.002746155049983451;0.6220465668840318;[IFNA5, IFNA4, IFNA7, IFNA2, GATA3, CD1C, IFNA8, IFNA21, IFNA14, FCER1G, IFNA16, SLC11A1, LILRB1, CLEC4D, IL18R1, IFNA10]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, PDGFRA, CXADR, CH25H, HOXB9, BIN2, AGTR1, PRKCQ, S100A8, EPHA2, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, NCKAP1L, CCR10, CCR1, TGFB2, EGR3, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, IL6, CXCL12, NRP1, CXCL6, CXCL9, HMGB2, CXCL1, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR2, ANXA1, FCER1G, SYK, RHOG, GAB1, VAV1, IL1B, KIT, XCL1, HBEGF, CX3CR1, CCL13, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, PF4]
GO:0031954;positive regulation of protein autophosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;6.481236761676141;0.026061291479152104;0.7466917612613706;[ACE, SYK, RAD50, GPNMB, PDGFD, PDGFC]
GO:0030509;BMP signaling pathway;11.0;0.7090535922965819;0.7869557484779532;9.133828010656014;282.55034729266697;5.202362649177086;0.009456705845082177;0.6984780201431826;[TMEM100, EGR1, TGFB2, TGFB1, USP9Y, RUNX2, RGMA, TGFBR3, BMP2, ID1, ENG]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[PYCARD, IFNA14, IFNA16, RNASE6, RNASE2, IFNA10, NLRP3, IFNA21, AZU1, DEFA1, CXCL10, IL6, PTPRC, SERINC5, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, IFNG, TLR8, TLR7, UNC93B1, SAMHD1, CARD9, LILRB1]
GO:0051604;protein maturation;5.0;0.5930994877375815;0.586790755729711;7.613621231949857;47.85814540089318;4.401795219996305;0.001601769057033345;0.5153490241159427;[POP5, UQCRC1, UQCRC2, ENPEP, PSEN2, TSPAN5, ACE, WFS1, DHCR24, CTSZ, PCSK6, CTSS, CTSH, CTSG, MME, HM13, CD5L, TSPAN33, HSPD1, F11, TSPAN15, NDUFAB1]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, LRRK2, SLC8A1, GRM5, EDNRB, CCRL2, CCR9, TNFSF11, CCR7, CCR6, CCR5, CCR2, AVPR1A, ATP1B1, LAT2, BTK, AGTR1, CX3CR1, CXCR5, CXCR4, FPR2, CXCR6, PLN, CXCR1, CXCR2, DMD, PLCG1, CCR10, CCR1, CCL20, AZU1, SELE, LAT]
GO:0071219;cellular response to molecule of bacterial origin;5.0;0.7980440201809971;0.6892630219514189;9.253830803050711;59.34640842185874;4.720827822332161;0.001986270881579593;0.5316643662359317;[CD86, CD80, CXCL13, PYCARD, EDNRB, GHSR, MEF2C, CD180, ADAM9, CD274, KLRK1, STAP1, NLRP3, ABCA1, FZD5, DEFA4, DEFA1, PPBP, NFKB1, CXCL10, CXCL11, IL6, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, CXCL3, CXCL2, CXCL5, PDE4B, CTSG, CD36, CCR5, HAVCR2, ARG1, PDCD1LG2, TNFRSF1B, TLR1, IL1B, TLR6, TLR4, TLR2, CX3CR1, CEBPE, CCL2, CCL20, NR1H2, LILRB1, LILRB2, MAPK14, FCGR2B, PF4]
GO:0031953;negative regulation of protein autophosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;780.3281191277907;7.379178354882098;0.026116879897493853;0.7926125360964777;[NLRP12, JUN, CAV1, ENG]
GO:0060672;epithelial cell morphogenesis involved in placental branching;7.0;1.0;0.8509193652572005;9.628524252492122;83.24866829651714;8.67846133901236;0.002786258008947111;0.7947362817240173;[ST14, SPINT2, GRHL2]
GO:2000170;positive regulation of peptidyl-cysteine S-nitrosylation;9.0;1.0;0.896240625180289;9.628524252492122;445.472383047836;9.083926447120524;0.014909559761494903;0.8607930461318132;[ACE]
GO:0060670;branching involved in labyrinthine layer morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;72.98998111856169;7.57984905034425;0.002442908981319996;0.710754145523778;[SPINT1, FZD5]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[TFRC, CLEC10A, KIAA1109, CUBN, SLC11A1, HSPG2, FPR2, IGHA1, ELANE, MSR1, MARCO, DENND1B, ASGR1, ASGR2, STAB1, CD36, ANXA1, FCER1G, SYK, ANXA3, CEACAM1, RHOU, CD302, CD5L, IGKC, CXCR1, CXCR2, SORT1, LILRB1, SIGLEC1, RAMP1, SCARB2, NCF4, HP, LY75, CXCL16, LOXL2, PYCARD, AP2M1, CD93, TSC2, PRTN3, CALCRL, PLD4, ADRB2, CORO1A, IGLV1-44, CD163, SYT2, CAV2, CAV1, LRP1B, MARCH3, IGKV3-20, LRP12, LRRK2, ITGB3, GHR, DNM2, PECAM1, COLEC12, NLGN1, LRP1, CEBPE, LRP2, DLL1, FCGR1B, ATP9A, NLGN4Y, CD6, CD9, FCGR2B]
GO:0060675;ureteric bud morphogenesis;9.0;1.0;0.896240625180289;9.628524252492122;52.20233752390303;8.67846133901236;0.0017471652578714015;0.8400575416471059;[TACSTD2]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[SCARB2, TFRC, HP, CXCL16, LOXL2, AP2M1, CUBN, HSPG2, CALCRL, FPR2, ADRB2, IGLV1-44, IGHA1, MSR1, CD163, CAV2, CAV1, LRP1B, MARCO, IGKV3-20, LRP12, ASGR1, ASGR2, STAB1, CD36, FCER1G, SYK, DNM2, CEACAM1, COLEC12, LRP1, CD5L, LRP2, DLL1, IGKC, CXCR1, CXCR2, FCGR1B, LILRB1, CD6, CD9, FCGR2B, RAMP1]
GO:0030855;epithelial cell differentiation;4.0;0.5489353771682173;0.5244676885841086;6.961296045910167;21.066225782797595;4.034070439870987;7.050676185779127E-4;0.45630254989846264;[EHF, LGALS3, BASP1, AKT1, HOXA5, SOX4, MEN1, MEF2C, EREG, COL4A1, ADAM9, HOXB5, EPHA2, GATA3, PSAP, FZD1, ST14, JUN, TGFB1, JAG1, BMP2, CD24, TGFB1I1, SLC7A11, TMEM100, HHEX, LBH, CD34, CTSB, DSP, ANXA1, PAX2, ELF3, YAP1, TAGLN, PCNA, E2F7, USH2A, GRHL2]
GO:0046034;ATP metabolic process;10.0;0.6519675769143192;0.7412248003180799;9.106334870075816;1262.3387643731025;4.99795013456894;0.04224934241243719;0.6708364141712261;[HK3, ATP1B1, ATP5J2, ADCYAP1, MSH2, UQCRC1, UQCRC2, UQCRB, ATP5J, ATP5I, ATP5H, ATP5O, COX5B, UQCRH, ATP5L, FIGNL1, CYC1, TGFB1]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[PLEKHF1, F11R, TNF, CDH1, FCER1G, GOLPH3L, TTC7B, ATP1B1, PKP3, TSPAN33, FLNA, TSPAN5, JUP, TSPAN15, RAMP1]
GO:0061551;trigeminal ganglion development;6.0;1.0;0.8231203125901445;9.628524252492122;32.51846529594618;8.390779266560578;0.0010883637687365787;0.7522251544931926;[NRP1]
GO:0014003;oligodendrocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;34.09911675737102;6.558197802812269;0.001141266750656509;0.6256275524841266;[LYN, EIF2B3, TGFB1, GSN, CD9, WASF3]
GO:0015695;organic cation transport;6.0;0.6260725219892441;0.6361565735847665;8.077926840080956;30.14448825076878;6.063501560976162;0.0010089088934751224;0.6332080644001243;[SLC22A4, SLC44A5, SLC44A1, ABCB4, SLC5A7, SLC7A8, RHCE]
GO:0036151;phosphatidylcholine acyl-chain remodeling;8.0;1.0;0.875;9.628524252492122;185.56639978848355;6.481236761676141;0.0062107404020032226;0.7064507494004503;[PNPLA8, LPCAT2, MBOAT2]
GO:0090197;positive regulation of chemokine secretion;10.0;0.8933024483968273;0.861892236059334;9.567899630675686;759.1048076819071;7.292166977892469;0.025406554763140368;0.7881627702307852;[PYCARD, CSF1R]
GO:1904953;Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation;8.0;0.8653626801206646;0.8076813400603323;9.427853557029971;31.415129658942366;7.474488534686424;0.0010514361179036673;0.7572456912631272;[FZD1]
GO:0061314;Notch signaling involved in heart development;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;57.16383262977075;7.57984905034425;0.0019132220340090946;0.738553198190834;[JAG1]
GO:0090191;negative regulation of branching involved in ureteric bud morphogenesis;8.0;0.8933024483968273;0.8216512241984136;9.577230958104572;298.2680508904603;8.390779266560578;0.009982763239485454;0.8041048419030481;[TACSTD2]
GO:1904835;dorsal root ganglion morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;28.42528359967652;9.777073627680469;9.513686609867987E-4;0.7902410118609202;[NRP1]
GO:0006855;drug transmembrane transport;5.0;0.5781283279524737;0.5793051758371571;7.293149336675085;29.084245973375534;5.407625775213448;9.73423538606871E-4;0.5667872454856517;[ABCB4, SLC1A3, SLC7A11, LRP2, SLC1A6, SLC17A6, SLC17A3, SLC19A2, ABCC3, ABCA8]
GO:0050772;positive regulation of axonogenesis;10.0;0.7436939687323844;0.7870879962271125;9.36383169826504;884.0118179988558;5.395046993006588;0.02958707998943757;0.6911439659786198;[ROBO2, CYFIP1, NRP1, PLXND1, PAK1, ARHGDIA, CXCL12, MAP1B]
GO:0002019;regulation of renal output by angiotensin;9.0;0.8653626801206646;0.8289219652406215;9.474373572664863;27.46031048587314;8.67846133901236;9.190718792872195E-4;0.8400575416471059;[ACE]
GO:2000178;negative regulation of neural precursor cell proliferation;6.0;0.7980440201809971;0.722142322680643;9.117698628726131;64.43316573945785;6.781341354126479;0.002156520071215264;0.6699184248047958;[TGFB1, SPINT1, IL1B, SPINT2]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, CYFIP1, TFRC, CLEC10A, SLA2, MYB, TRBC1, C3AR1, UBASH3A, PRKACB, MEF2C, CXADR, PRKCQ, HHLA2, FPR1, FPR3, FPR2, GATA3, KLRK1, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, ELANE, LYN, JUN, HLA-DRB4, FZD5, KIR2DS1, KIR2DS2, COL1A1, HLA-DRB1, DENND1B, ITK, SIGLEC9, CTLA4, HLA-DPA1, HAVCR2, ANXA1, ARG1, IFNGR1, FCRL3, NFAM1, PAWR, SERPINB9, PAX5, FOS, SIRT1, MMP12, FCER2, TLR10, HLA-DQB1, PTAFR, UNG, HLA-DMB, CCL19, IL12RB1, NR1H2, CARD9, KIR3DL1, HLA-DPB1, PKN1, CLC, LGR4, PROS1, CXCL13, TNF, PYCARD, IGHG1, FCGRT, GRAP2, IL13RA2, CD177, LAG3, CD180, MSH6, ADCYAP1, CLEC4D, MSH2, S100A8, BLK, CD274, LY96, CLEC7A, IGLV1-44, MAP2K6, EIF2B3, BMX, NFKB1, PTPRC, BCL6, HLA-DRA, LAT, MYD88, ITGAM, TREM2, PTPN22, TREM1, TNFSF13B, FCGR3A, DUSP10, CR2, CR1, CHUK, PVRIG, LCK, XCL1, LCP2, UNC93B1, NLRC4, CCL5, FYN, CSK, FCGR1B, FCGR2A, PTPN6, MNDA, CD247, FCGR2B, CLEC2D, ICAM2, LGALS3, ICOSLG, SLC11A1, MIF, EREG, BTK, STXBP2, CD1E, CD1D, CD1C, CD1B, CD1A, CD79B, CD79A, CD19, INPP5D, SLAMF7, PAG1, SH2D1A, TNFSF13, PTK2, MARCO, CD28, CD24, CD200, IGHM, ECM1, CD40, IFNA2, CD3G, CD3E, CD3D, CTSS, RAC2, FCER1A, CTSH, FFAR2, CTSG, CCR7, MUC15, CD36, CD34, CD33, CCR2, FCER1G, SYK, LIME1, VAV1, LAT2, TLR1, NCR1, HCK, CEACAM1, IL1B, KIT, IGHD, TLR8, TLR7, TLR6, TLR5, TLR4, TLR2, C1QA, PAK1, IGKC, NPDC1, LILRB1, LILRB2, MLH1, CD40LG, CD86, CD80, TRAC, IL18RAP, IL6R, CD96, THEMIS, OSCAR, KLRF1, CD300C, CARD11, KLRB1, C5AR1, KIR2DL1, KIR2DL2, CACNA1F, KIR2DL3, KIR2DL4, STAP1, NLRP3, TGFB2, TGFB1, CAV1, NFKBIA, IL6, NR4A3, KLRD1, IGKV3-20, HMGB2, TNFAIP3, PDE4B, IRAK3, FGR, ZAP70, IFNG, LTA, LTF, COLEC12, CLEC12B, SAMHD1, HSPD1, CNR1, TRAT1, MAPK14, CD4]
GO:0019805;quinolinate biosynthetic process;8.0;1.0;0.875;9.628524252492122;691.6482702327052;8.67846133901236;0.023148845161657855;0.8188169164668168;[KMO]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, HLA-DPA1, IFNGR1, HCK, IFNG, HLA-DQB1, PTAFR, NCAM1, FCGR1B, HLA-DQA2, HLA-DQA1, HLA-DRB4, HLA-DPB1, HLA-DRA, HLA-DRB1]
GO:0061549;sympathetic ganglion development;5.0;1.0;0.7902410118609202;9.628524252492122;31.419853007278505;7.57984905034425;0.0010515942041217404;0.6778748447945537;[NRP1, NRP2]
GO:0060218;hematopoietic stem cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;45.53364894725875;7.379178354882098;0.0015239702526411902;0.6676125360964777;[ACE, HOXB4]
GO:1901215;negative regulation of neuron death;6.0;0.7586651285174919;0.7024528768488905;9.05316010758856;58.54459561550999;4.545965010825883;0.001959434928535777;0.5556011746527726;[AKT1, MEF2C, F2R, MSH2, NAIP, C5AR1, SLC30A10, CORO1A, FZD1, JUN, WFS1, NR4A2, NR4A3, NRP1, LRRK2, CHL1, CD34, SIRT1, LRP1, GPNMB, NTF3, CCL2, FYN, GABRA5]
GO:0048469;cell maturation;3.0;0.6954798709641801;0.5458602480722345;8.242229891372231;25.22197897315013;4.886724499458715;8.441569379239579E-4;0.4480276307483924;[CDKN1A, BRCA2, ROPN1L, FBXO5, HOXA5, RUNX2, EREG, BTK, CFTR, GATA3, CCL19, FZD5, CCL21, NR4A2, SLC26A8, PLP1, SLC26A3]
GO:0061309;cardiac neural crest cell development involved in outflow tract morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;64.99956039719679;8.67846133901236;0.0021754767906876885;0.7947362817240173;[JAG1]
GO:0060334;regulation of interferon-gamma-mediated signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;117.87544056254812;6.558197802812269;0.003945184914619341;0.7103865406232063;[ARG1, IFNGR1, NR1H2, IFNG]
GO:1901216;positive regulation of neuron death;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;58.38287487682085;5.370354380416217;0.001954022280951067;0.5977604853516485;[ITGAM, CTSZ, FASLG, MYB, FOS, KMO, IL1B, TLR6, TLR4, TP53BP2, FYN, EGR1, JUN, TGFB2, EIF2S1, FCGR2B, UBE2M]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[CXCL13, SLC8A1, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, PDGFRA, F2R, ATP1B1, ADCYAP1, AGTR1, CALCA, C5AR1, FPR1, FPR3, FPR2, PKHD1, CD19, HRH4, PLCG1, ELANE, CCR10, DRD4, CCR1, TGFB1, WFS1, CAV1, CXCL10, CXCL11, CXCL12, PTPRC, CD24, GPR18, CXCL9, CD40, ATP2A3, FASLG, GRM5, JPH2, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, TRPC7, CD52, PTGIR, TRPC3, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, SLC24A2, SLC24A1, CCL13, SLC24A4, PTGER2, CXCR5, CXCR4, KCNA5, CXCR6, ATP2C2, CCL8, PLN, CXCR1, CCL7, SV2A, CCL5, CXCR2, S1PR3, CCL1, CCL19, GPR157, CCL23, CCL21, TMEM64, GPR6, P2RX5, CD4, GRINA, F2RL3]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[RUVBL2, TLE4, AXIN2, AES, SFRP4, SFRP2, PFDN5, FOXO1, FRZB, CTHRC1, FZD1, EGR1, CAV1, TMEM64, MAPK14, BMP2]
GO:0045086;positive regulation of interleukin-2 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.292166977892469;0.027942676825076673;0.747921758369865;[CD86, CD4, CD80, IL1B, CD28, PRKCQ, CD3E, CARD11]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, CD80, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, ADAM9, TLR4, CX3CR1, CD274, CEBPE, KLRK1, STAP1, NLRP3, CCL2, ABCA1, CCL20, NR1H2, DEFA4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, PF4]
GO:0006509;membrane protein ectodomain proteolysis;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;50.748517158788495;6.781341354126479;0.0016985071986044009;0.6977174774718518;[PSEN2, ADAM9, PRTN3, PRKCQ, RBMX]
GO:0071223;cellular response to lipoteichoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;155.87545856417063;7.474488534686424;0.005217011319337755;0.7053660038532718;[CCL20, TREM2, CD36, MAPK14, TLR2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, SLA2, LGALS3, TRBC1, RNASE6, RNASE3, MIF, SLPI, BTK, PADI4, TRIM10, NAIP, GATA3, CD1D, LY9, KLRK1, SLAMF7, IGHA1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, PTK2, MARCO, VNN1, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QA, LILRA5, IGKC, CARD9, KIR3DL1, LGR4, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, CLEC4D, S100A8, IFNA10, BLK, CSF1R, LY96, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, DEFA1, BMX, NFKB1, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, FGR, ZAP70, LCK, LTF, COLEC12, UNC93B1, HIST1H2BK, NLRC4, FYN, CSK, CD6, PTX3, PTPN6, CD244]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, FPR2, TNFRSF11A, SLC30A10, PDGFD, PDGFC, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, CHI3L1, XCL1, CCL13, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[, UQCRC1, PRKCQ, UQCRC2, ENPEP, GATA3, ADAMTS12, ELANE, BARD1, ST14, ACE, HACE1, AZU1, TGFB1I1, MMP28, OLR1, SIRT1, MMP12, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, MMP19, FAM105A, ADAM28, USP9Y, F11, PSMC6, PSMC2, APEH, IGHG1, RUVBL1, FBXW2, CDC25A, ADAM2, ADAM9, ADAM7, CUL5, IGLV1-44, CLCA4, WFS1, DHCR24, NFKB1, COPS5, ADAMTS1, ADAMTS20, HM13, RNF24, EIF3F, ANPEP, SKP2, CFTR, CTSZ, BRCA1, PCSK6, CTSS, CTSH, CTSG, CTSB, MME, RNF144B, C1QA, CD5L, IGKC, RANBP2, RANBP1, PCOLCE, ADAM12, PRTN3, PSMD14, PSEN2, ADRB2, TRHDE, DPP4, NLRP3, TGFB1, UBE2C, NFKBIA, IGKV3-20, TNFAIP3, MMP8, MMP9, CCNA2, LTF, RBMX]
GO:0048596;embryonic camera-type eye morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;49.04309196241917;7.292166977892469;0.0016414281520649497;0.7238411236270654;[FZD5]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[CCL13, CD40, ADAMTS12, PYCARD, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, KMO, NFKB1, CHI3L1, XCL1, RBMX, IL17A]
GO:0071224;cellular response to peptidoglycan;6.0;1.0;0.8231203125901445;9.628524252492122;318.29655603595194;8.16763571524637;0.010653099282220678;0.7408135829017477;[NLRP3, TREM2]
GO:0070498;interleukin-1-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.845247994956144;0.00101047745553359;0.6498456195510879;[EGR1, CHUK, IL1R1, IL1R2, IRAK3, NFKB1, NFKBIA, IL1B, MYD88]
GO:0043507;positive regulation of JUN kinase activity;13.0;0.8653626801206646;0.8952363048279688;9.582714716460828;4931.413721535565;5.459585514144159;0.16504997927558432;0.7417584218576596;[TNF, TNFSF11, MAP4K1, SYK, MDFIC, IL1B, TLR6, TNFRSF11A, PAK1, CCL19, FZD5, CD40LG, PKN1]
GO:0045807;positive regulation of endocytosis;7.0;0.6873818243518346;0.6946102774331178;8.89763674394933;124.48668476360231;4.886724499458715;0.0041664573082951335;0.6008266834154484;[LRRK2, FMR1, SIRPG, TNF, SIRPB1, PYCARD, CD36, FCER1G, SYK, SLC11A1, ACTN4, DNM2, SFRP4, IL1B, NLGN1, CD151, LRP1, DLL1, RAB21, NTF3, STAP1, CCL2, NCKAP1L, CCL19, CCL21, EGF, AZU1, SELE, PTX3, FCGR2B]
GO:1902033;regulation of hematopoietic stem cell proliferation;6.0;0.8933024483968273;0.7697715367885581;9.461470167828956;57.23280282053753;7.9853141584524145;0.001915530404224917;0.7314896500084853;[ACE]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, GATA3, LYN, ABCA1, COL1A1, MMP12, GOPC, CSE1L, AP2M1, ADCYAP1, ACAP1, SLC27A2, LIN7A, EVI5, TNFSF13B, ITGB6, LCP2, LRP1, LRP2, GOLPH3L, ACTN4, MSR1, EGR2, POLA2, CD24, CD3G, CCR7, CD36, SYK, HSD17B4, STX11, RAMP1, SCARB2, CARD11, NUP155, NASP, NUP62, NUP133, TBC1D9, CHI3L1, NUP54, NUP35, RAN, PHB2, CUBN, NUP85, NUP88, DENND1B, ANXA1, CCL19, TNF, LAMP2, RAB32, CALCRL, BCL6, CCDC22, NLGN1, UNC93B1, NLRC4, RAB21, VPS41, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, CD40LG, NUPL2, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, DNM2, IFNG, EHHADH, HSPD1]
GO:0051491;positive regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;6.409777797693995;0.006704083591926775;0.7240369598395108;[NRP1, NLGN1, CCL21, FMR1, ARAP1, CCR7]
GO:0002084;protein depalmitoylation;8.0;1.0;0.875;9.628524252492122;372.9036028239795;7.57984905034425;0.012480747995064495;0.7626338329336335;[ABHD12]
GO:0006564;L-serine biosynthetic process;10.0;1.0;0.9152410118609203;9.628524252492122;563.0954422464521;7.8311634786251565;0.01884629769899192;0.8157270763441555;[SERINC5]
GO:0097490;sympathetic neuron projection extension;5.0;1.0;0.7902410118609202;9.628524252492122;51.99108915072818;8.390779266560578;0.0017400949649324319;0.7193458537639684;[NRP1, NRP2]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[CSF1R, CD40, IFNA2, GHR, CCL5, FYN, IL6R, LYN, LIF, GH1, IL6, IFNG, KIT]
GO:0007413;axonal fasciculation;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;31.514364772604104;6.7325511899570465;0.0010547574278521217;0.6952223462072524;[NRP1, CNR1, NCAM2, EPHA3]
GO:0072070;loop of Henle development;8.0;0.9326813400603323;0.8413406700301662;9.533214072687796;58.05347923817328;8.390779266560578;0.001942997705362361;0.8041048419030481;[JAG1, DLL1]
GO:1904219;positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity;6.0;1.0;0.8231203125901445;9.628524252492122;49.122279745261444;8.67846133901236;0.0016440784958923031;0.7669372290569613;[SERINC5]
GO:0032967;positive regulation of collagen biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;105.22247330055487;6.558197802812269;0.003521701487291661;0.6585068532133508;[PDGFRB, TGFB1, MYB, F2R, ENG, CTGF]
GO:0007409;axonogenesis;8.0;0.6873818243518346;0.7186909121759173;8.667113085337498;64.60914726719044;4.956792062075433;0.0021624100145753813;0.6284905765689417;[NRP1, STMN1, EPHB1, DCC, PAX2, MAP1B, DSCAML1, SLITRK6, LINGO1, GP5, PTK2, NR4A2, LRFN4, OGN]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[PTPN22, CD3E, TNF, PYCARD, PDE4B, IL6R, CCR2, HLA-DPA1, HAVCR2, SLC11A1, IL1B, LTA, TLR8, TLR7, TLR4, HSPD1, KLRK1, IL12RB1, IL12RB2, FZD5, CD2, HLA-DPB1, IL18R1, CD244]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[CTSS, HLA-DOA, HLA-DOB, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, HLA-DRB4, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0032720;negative regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.92712208559752;5.926926025970411;0.002875903446815721;0.6540226378555745;[ORM1, TNFAIP3, TWIST1, PTPN22, GPNMB, CD34, HAVCR2, GHSR, LILRB1, IRAK3, BPI, TLR4, GPR18]
GO:0021828;gonadotrophin-releasing hormone neuronal migration to the hypothalamus;11.0;1.0;0.9324289523296623;9.628524252492122;88.9737192139704;9.083926447120524;0.002977870310942956;0.8969813732811862;[NRP1]
GO:1903375;facioacoustic ganglion development;6.0;1.0;0.8231203125901445;9.628524252492122;32.51846529594618;9.083926447120524;0.0010883637687365787;0.7876727335416686;[NRP1]
GO:0038145;macrophage colony-stimulating factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;8.67846133901236;0.00101047745553359;0.7947362817240173;[CSF1R]
GO:1902287;semaphorin-plexin signaling pathway involved in axon guidance;8.0;1.0;0.875;9.628524252492122;28.581916314885376;7.292166977892469;9.566110170045473E-4;0.747921758369865;[NRP1, PLXND1]
GO:1904222;positive regulation of serine C-palmitoyltransferase activity;6.0;1.0;0.8231203125901445;9.628524252492122;49.122279745261444;8.67846133901236;0.0016440784958923031;0.7669372290569613;[SERINC5]
GO:1904469;positive regulation of tumor necrosis factor secretion;10.0;1.0;0.9152410118609203;9.628524252492122;775.9675723657698;7.292166977892469;0.025970936321606315;0.7881627702307852;[ORM1, FZD5, LRRK2, HAVCR2]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, SLC8A1, IL18RAP, MYB, CYP1B1, PDGFRB, ANXA1, DUSP1, ARG1, SIRT1, PAX2, ADAM9, PCNA, KCNA5, FOXO1, PDGFD, JUN, COL1A1, IL6, NR4A3, SDC1, EZH2]
GO:0006699;bile acid biosynthetic process;8.0;1.0;0.875;9.628524252492122;493.34951140512965;6.481236761676141;0.01651196416099542;0.7064507494004503;[OSBPL7, HSD17B4, CH25H, SLC27A2]
GO:0007416;synapse assembly;4.0;0.8436909121759173;0.6718454560879586;9.117698628726131;35.85243951974866;5.500407508664414;0.0011999488856252476;0.5312910957882058;[NLGN1, FZD5, PLXND1, PCDHB15, PCDHB14, PCDHB10, CDH1, PCDHB16, SLITRK6, PCDHB4, PCDHB8]
GO:0006569;tryptophan catabolic process;9.0;0.8436909121759173;0.8180860812682478;9.539576766475626;1971.8984750997497;7.474488534686424;0.06599766736817739;0.7784863164434164;[KMO, ACMSD]
GO:0051497;negative regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;338.83785420150645;6.781341354126479;0.01134059804585365;0.7792270645443136;[TMEFF2, STMN1, TACSTD2, ARAP1, PFN1, ARHGAP6]
GO:0051496;positive regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;365.07497849775285;5.926926025970411;0.012218730984170163;0.735532224928036;[NRP1, ARHGEF10L, CTGF, PAK1, TPM1, NOX4]
GO:0016485;protein processing;6.0;0.6519675769143192;0.6491041010473041;8.320191432841943;99.81063536400724;4.720827822332161;0.0033405721418933456;0.564543666965156;[CTSZ, PCSK6, CTSS, CTSH, CTSG, MME, UQCRC1, UQCRC2, ENPEP, HM13, CD5L, PSEN2, ACE, F11, DHCR24]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[CALCRL, LRP1, TFRC, CXCR1, CXCR2, CD36, AP2M1, FCER1G, SYK, CAV1, LILRB1, DNM2, CEACAM1, CD9, RAMP1]
GO:0016126;sterol biosynthetic process;6.0;0.7980440201809971;0.722142322680643;9.292052015870908;224.1590834480148;5.885253329569843;0.007502402792927377;0.6240924415566148;[DHCR24, CH25H, CFTR]
GO:0014047;glutamate secretion;10.0;0.9326813400603323;0.8815816818910864;9.574457031221845;161.52301102016722;6.8867018697843045;0.005406029817572731;0.7674272657460779;[SLC1A3, SLC1A6]
GO:1903146;regulation of autophagy of mitochondrion;7.0;0.7369933605727446;0.7194160455435727;9.280217558223907;66.7923696051344;6.088194173566533;0.0022354805014538253;0.6622698984233759;[FZD5, TSC2]
GO:0051271;negative regulation of cellular component movement;5.0;0.5470854108181258;0.5637837172699831;7.364160372318274;52.38761662992485;4.128099389519264;0.001753366382809582;0.5013522066171892;[SEMA5B, SPINT2, CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, ACTN1, TPM1, ACTN4, MIF, SFRP2, PADI2, VCL, KCNE3, TACSTD2, FBLN1, GATA3, PKHD1, KLRK1, STAP1, TGFB1, JAG1, JUP, CXCL12, GPR18, NRP1, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, TGFBR3, TMEFF2, ENG, CX3CR1, LRP1, THBS1, SPOCK3, CCL2, CCL21, SEMA4B, TIE1, PODN, CD9]
GO:0003273;cell migration involved in endocardial cushion formation;6.0;1.0;0.8231203125901445;9.628524252492122;22.825287336738096;8.390779266560578;7.639418257356832E-4;0.7522251544931926;[ENG]
GO:0006663;platelet activating factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;769.8004963599423;8.390779266560578;0.025764529837699335;0.8041048419030481;[LPCAT2]
GO:0006660;phosphatidylserine catabolic process;8.0;1.0;0.875;9.628524252492122;837.3304422023242;9.777073627680469;0.028024696352038317;0.875;[ABHD12]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NKX2-3, JUN, JAG1, JUP, FZD5, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, PSMC6, PSMC2, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, CIITA, CYR61, HHEX, PPP1R12A, CHUK, PEG3, CEBPE, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, SFRP2, BEX1, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, CD40, PRL, BRCA1, CD3D, RGMA, IL1B, TLR4, TLR2, YAP1, LILRB1, GRHL2, IL17A, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, DCN, ELF3, TAF9, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, CHL1, MEF2C, F2R, MSH2, NAIP, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, FYN, JUN, WFS1, GABRA5, NR4A2, NR4A3]
GO:0006665;sphingolipid metabolic process;6.0;0.6073376606709605;0.6267891429256247;8.442900586834382;65.68188383398223;4.786641040901733;0.0021983135420656713;0.5679093580234316;[GAL3ST1, GM2A, PPP2R1A, ITGB8, ELOVL4, ELOVL6, ELOVL7, KIT, SGMS1, PSAP, SGPP2, P2RX1, SERINC5]
GO:0007628;adult walking behavior;4.0;1.0;0.75;9.628524252492122;34.938319875750295;6.518977089658987;0.0011693541237948906;0.5833807915285978;[ABHD12, SCN1A]
GO:0006537;glutamate biosynthetic process;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;829.4659717023219;8.16763571524637;0.027761479601967176;0.8329342821725234;[SLC1A3]
GO:0006658;phosphatidylserine metabolic process;7.0;0.8653626801206646;0.7836007053175329;9.466005322994347;192.1199672242072;6.375876246018314;0.00643008240624912;0.6769819729871445;[ABHD12, SERINC5]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, TNF, ALAD, GHSR, ANXA1, DUSP1, ANXA3, ARG1, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, ABCB4, PTAFR, PTGS2, FOXO1, IGFBP7, TGFB1, IL6, ALPL, SDC1]
GO:1903278;positive regulation of sodium ion export across plasma membrane;10.0;1.0;0.9152410118609203;9.628524252492122;363.3657930958667;8.390779266560578;0.012161526086936028;0.8443458537639685;[ATP1B2, ATP1B1]
GO:0044861;protein transport into plasma membrane raft;11.0;1.0;0.9324289523296623;9.628524252492122;279.98422179103943;9.083926447120524;0.009370819933905719;0.8969813732811862;[ATP1B1]
GO:0035094;response to nicotine;4.0;0.9326813400603323;0.7163406700301662;9.446202695698167;26.17342148764107;5.926926025970411;8.760008626412986E-4;0.5531032725983739;[CHRNB4, SLC7A11, TNF, NFKB1, CNR1]
GO:0042447;hormone catabolic process;5.0;0.657518819034173;0.6190004213780067;8.048073876931273;28.890480996358985;7.138016298065211;9.669383992032849E-4;0.6552794972956795;[ACE]
GO:0030514;negative regulation of BMP signaling pathway;12.0;0.8259837884571596;0.8611122068187244;9.4949928598676;599.3292772798114;5.905872616772578;0.02005901154922404;0.7501469128630576;[FZD1, LRP2, SFRP2]
GO:0030513;positive regulation of BMP signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.571365838652174;514.640204837359;6.311337724880743;0.017224544509792043;0.770882417347765;[CYR61, ENG]
GO:0097475;motor neuron migration;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;22.707504301080803;7.8311634786251565;7.599997335300838E-4;0.7236063770733796;[NRP1]
GO:0031960;response to corticosteroid;6.0;0.7140352122741334;0.6801379187272112;9.05316010758856;61.63829009254609;4.689477292448085;0.0020629780985379075;0.5629403994089356;[CDKN1A, TNF, CTGF, ALAD, GHSR, ANXA1, DUSP1, ANXA3, ARG1, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, ENG, PCNA, ABCB4, PTAFR, PTGS2, FOXO1, IGFBP7, TGFB1, COL1A1, IL6, ALPL, SDC1]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[IL5RA, SLA2, FGF5, EFEMP1, GRAP2, EPHB1, PDGFRB, PDGFRA, MAP2K2, EREG, BTC, MELK, BTK, EPHA3, EPHA2, BLK, CSF1R, CSF2RB, MAP2K6, LYN, LIF, BMX, CLK4, PTK2, CLK1, ITK, GHR, SYK, FGR, ZAP70, HCK, LCK, KIT, IL3RA, HBEGF, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:1902475;L-alpha-amino acid transmembrane transport;10.0;0.6181399273706679;0.7243109755462542;8.529911963824013;268.42115299878213;6.063501560976162;0.00898381442751516;0.7253287636709003;[SLC38A1, SLC43A2, SLC1A3, SLC7A11, SLC1A6, SLC7A5, SLC7A7, SLC7A8, SLC17A6]
GO:1902476;chloride transmembrane transport;8.0;1.0;0.875;9.628524252492122;110.5175749436453;5.311165509025885;0.0036989237740038075;0.6466132511260384;[GABRB1, TTYH3, TTYH2, SLC1A3, SLC26A11, GABRE, CLCA4, SLC12A2, GABRA5, SLC12A1, CLDN4, SLC26A8, SLC26A7, CLDN17, SLC26A3, CFTR]
GO:0021879;forebrain neuron differentiation;6.0;0.7980440201809971;0.722142322680643;9.0094850440859;26.729186262933762;7.069023426578259;8.946018095145202E-4;0.6846304993685643;[CSF1R, BCL11B, INHBA]
GO:1902358;sulfate transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;123.29733532969695;7.069023426578259;0.0041266508530873195;0.7365101867784198;[SLC13A1, SLC26A8, SLC26A7, SLC26A11, SLC26A3]
GO:1903204;negative regulation of oxidative stress-induced neuron death;9.0;0.8653626801206646;0.8289219652406215;9.582004236857228;363.9833276048854;6.8867018697843045;0.012182194411207908;0.7484268790654467;[FZD1, NR4A3]
GO:0006488;dolichol-linked oligosaccharide biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;80.91159753301743;7.069023426578259;0.00270803835371991;0.6846304993685643;[ALG8, SRD5A3]
GO:0006489;dolichyl diphosphate biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;346.04394917679554;8.16763571524637;0.011581779559612143;0.7686126355688037;[SRD5A3]
GO:0052651;monoacylglycerol catabolic process;8.0;1.0;0.875;9.628524252492122;491.79843549514675;9.083926447120524;0.016460051046165984;0.839552420951524;[ABHD12]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, ADCYAP1, MAP1B, EPHA3, LYN, FZD1, SYT2, CXCL12, EZH2, ROBO2, NRP1, NLGN1, RAB21, PAK1, CNR1, FYN]
GO:0030224;monocyte differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;69.52661413212034;7.004484905440688;0.0023269932051117304;0.6813299963962409;[CSF1R, MEF2C, JUN]
GO:0030225;macrophage differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.8867018697843045;0.0015755275618510598;0.6753065664753021;[CSF1R, SPI1, CEBPE, MMP9, SIRT1, NKX2-3]
GO:0042987;amyloid precursor protein catabolic process;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;48.551292581453126;7.57984905034425;0.0016249680693747237;0.710754145523778;[PSEN2, DHCR24]
GO:0007220;Notch receptor processing;6.0;1.0;0.8231203125901445;9.628524252492122;83.35257022185557;7.379178354882098;0.0027897355128825266;0.7004918368257019;[PSEN2]
GO:0007223;Wnt signaling pathway, calcium modulating pathway;9.0;1.0;0.896240625180289;9.628524252492122;33.206889128170424;6.250713103064308;0.001111404694859899;0.7159023839588838;[FZD5]
GO:1905516;positive regulation of fertilization;5.0;0.8653626801206646;0.7229223519212526;9.427853557029971;78.82632625976231;7.292166977892469;0.0026382462008263663;0.6631627702307852;[LHFPL2]
GO:0007221;positive regulation of transcription of Notch receptor target;12.0;1.0;0.9481203125901445;9.628524252492122;1467.8987330058965;6.8867018697843045;0.04912924957061573;0.8003065664753022;[PLXND1]
GO:0007342;fusion of sperm to egg plasma membrane involved in single fertilization;6.0;1.0;0.8231203125901445;9.628524252492122;41.84633322739465;7.004484905440688;0.0014005591138660403;0.6813299963962409;[ADAM2, CD9, FOLR3]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, HP, CXCL13, TNF, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, RNASE6, RNASE3, CLEC4D, SLPI, S100A8, SEH1L, C5AR1, KLRK1, NLRP3, S100A14, IGHA1, ELANE, DEFA4, PRG2, AZU1, DEFA1, PPBP, LYZ, IL6, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, STAB1, CTSG, CD36, CAMP, HAVCR2, FCER1G, SYK, ANXA3, TLR1, FGR, IGHD, LTA, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPE, HIST1H2BK, NLRC4, IGKC, CCL20, CARD9, CD4]
GO:0030216;keratinocyte differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;25.58801435984686;5.486614186532078;8.564078129062366E-4;0.6037060172430475;[DSP, YAP1, ST14, JAG1, ANXA1, EREG, ADAM9, EPHA2]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[SPI1, EHMT2, SLA2, AKT1, MEF2A, MEF2C, ATF3, GATA3, IQGAP3, JUN, PKIG, EZH2, SIRT1, MMP12, BTAF1, FLNA, LGR4, GMNN, CTGF, FOXO1, NFKB1, CIITA, LRRK2, FASLG, HHEX, ITGB8, PEG3, E2F1, FYN, E2F7, PRRX1, EIF3E, UXT, MIF, EREG, SFRP2, IFI27, KCNQ1, NAIP, PCBP3, CCR1, EGR1, MSR1, ID1, CD28, CTSZ, PTPRK, BRCA1, CD3E, CD36, CD34, BANK1, IL1B, LOXL2, CCNE1, CALCA, CAV1, HMGA1, BMP2, MXD1, HMGB2, MYOCD, ELF3, FBP1, PHB2, MYB, HOXA2, HOXA7, HOXB4, HOXB3, PRDM16, ELANE, BARD1, FZD1, NDFIP2, CDKN1A, HAVCR2, PAWR, PAX5, PAX2, AES, GAS1, ENG, NR1H2, FMR1, TNF, DACH1, MEN1, TLE4, MAP2K2, NACC2, WFS1, LSM5, LSM3, BCL6, CNOT3, PTPN22, EMILIN1, CR1, RFC1, PTBP2, XCL1, NLRC4, RBBP8, ZNF503, KLF8, KLF5, DNAJA3, ZNF608, EDNRB, PPP2R1A, MAGOH, DPF3, SOX4, IL1R2, RUNX2, TWIST1, BCL11A, IFNA2, XPO1, CBFA2T3, MDFIC, MLH1, ARID4A, CHCHD3, BASP1, TGFB2, TGFB1, CBX4, EIF2S1, NR4A2, LIN28A, NR4A3, CREBZF, IFNG, PFDN5, THBS1, MEIS2, RBMX]
GO:0051453;regulation of intracellular pH;10.0;0.7192862368539868;0.7748841302879137;9.242861771680136;143.07278219841277;5.407625775213448;0.004788517263036519;0.6917872454856517;[LRRK2, FASLG, SLC4A3, SLC26A11, SLC11A1, AVPR1A, SLC4A7, SLC26A8, SLC26A7, SLC26A3, CFTR]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[TMEM100, HHEX, FCER2, PSEN2, KCNA5, DLL1, PLN, S1PR3, TGFB1, JAG1, KRT19, BMP2]
GO:0072015;glomerular visceral epithelial cell development;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;35.73672554677016;7.474488534686424;0.0011960760430854717;0.7053660038532718;[JAG1]
GO:0050482;arachidonic acid secretion;12.0;1.0;0.9481203125901445;9.628524252492122;224.85573033724626;6.599019797332524;0.007525718937368459;0.7855944919115336;[ACE, ANXA1, PNPLA8, DRD4]
GO:0016042;lipid catabolic process;4.0;0.5127202928476964;0.5063601464238482;6.883086519318291;43.14795622097559;4.114113147544524;0.0014441232640765526;0.4603959376912539;[ABHD12, CYP1B1, SLC27A2, PLD4, PLA2G7, PLD3, PLCG1, RARRES3, CYP4F2, FUCA1, CYP4F3, SRD5A3, CYP4F12, ETFA, GM2A, ACADM, HIBCH, CYP4A11, EHHADH, HSD17B4, CYP3A4, PNPLA8, FABP7, PNPLA6]
GO:0072017;distal tubule development;8.0;0.8653626801206646;0.8076813400603323;9.36615998802463;58.05347923817328;8.390779266560578;0.001942997705362361;0.8041048419030481;[JAG1]
GO:0001916;positive regulation of T cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.523163736834295;365.14378084230765;6.518977089658987;0.012221033736724321;0.7296214167088868;[CD1E, CD1D, CD1C, CD1B, CD1A, XCL1, IL12RB1]
GO:0030334;regulation of cell migration;6.0;0.4770562410916853;0.5616484331359872;7.1128459440373675;36.74126027361157;3.1319826581748256;0.0012296969163702938;0.48329005138129355;[MYLK, C3AR1, AKT1, CYP1B1, HOXA7, MEF2C, PADI2, FPR2, GATA3, PLA2G7, EPB41L5, KLRK1, FLRT2, PDGFD, PDGFC, NCKAP1L, S100A14, PLCG1, ELANE, LYN, JUN, JAG1, ACE, HACE1, JUP, PLK2, COL1A1, NOX4, GPR18, ARHGAP4, MMP28, TIMP1, ANXA1, ANXA3, SIRT1, TMEFF2, HBEGF, ENG, PTAFR, PTGS2, GPNMB, NTF3, FLNA, CCL19, JAM3, CCL21, CCL20, PF4, SEMA5B, PLXND1, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, DACH1, F2R, TPM1, ADAM9, CD274, CSF1R, CD151, TACSTD2, CORO1A, CXCL10, CXCL11, CXCL12, PTPRC, ITGB3, CYR61, DUSP10, EMILIN1, XCL1, CX3CR1, LRP1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, SEMA4B, TIE1, LGALS3, IL1R1, ACTN4, MIF, SFRP2, PFN1, EPHA2, CCR1, TNFSF14, PPBP, PTK2, BST1, NRP1, PTPRR, NRP2, ECM1, CD40, PTPRK, RAC2, CTSH, CCR7, CCR6, CCR2, GAB1, CEACAM1, CEACAM6, IL1B, KIT, SGK1, GNAI2, PAK1, CXCR2, PDPN, MPP1, PODN, ARHGDIB, IL6R, PDGFRB, PDGFRA, VCL, C5AR1, STAP1, TGFB2, TGFB1, IL6, BMP2, NR4A3, DOCK5, CXCL6, CXCL9, MCTP1, TNFAIP6, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, MYOCD, ARAP3, MMP9, DCN, FGR, IFNG, LAMA3, THBS1, EGF, LAMB1, MAPK14, TEK]
GO:0017015;regulation of transforming growth factor beta receptor signaling pathway;7.0;0.811012628672052;0.7564256795932265;9.318369324188282;71.23621840810117;5.132682728539097;0.0023842121216848507;0.6134049986888465;[TGFB1I1, EMILIN1, MEN1, MYOCD, SIRT1, DNM2, TGFBR3, ENG, THBS1, PRDM16, TGFB1, CAV2, CAV1, LRG1]
GO:0010862;positive regulation of pathway-restricted SMAD protein phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1012.5567145242198;5.905872616772578;0.033889361993245395;0.7172676121338334;[TGFB2, TGFB1, INHBA, BMP2, ENG]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, TPM1, MIF, SFRP2, PADI2, VCL, TACSTD2, KLRK1, STAP1, TGFB1, JAG1, JUP, CXCL12, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, TMEFF2, ENG, CX3CR1, LRP1, THBS1, CCL2, CCL21, TIE1, PODN]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[MYLK, LGALS3, C3AR1, AKT1, IL1R1, ACTN4, PFN1, FPR2, GATA3, PLA2G7, EPB41L5, PDGFD, PDGFC, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, PPBP, PTK2, COL1A1, NOX4, NRP1, NRP2, CD40, RAC2, CTSH, CCR7, CCR6, CCR2, ANXA1, ANXA3, GAB1, SIRT1, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CCL21, CCL20, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, IL6R, PDGFRB, PDGFRA, F2R, ADAM9, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PTPRC, NR4A3, DOCK5, CXCL6, CXCL9, TNFAIP6, ITGB3, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, CYR61, MMP9, FGR, IFNG, XCL1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, EGF, SEMA4B, LAMB1, MAPK14, TEK]
GO:1901166;neural crest cell migration involved in autonomic nervous system development;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;23.960267269578353;8.390779266560578;8.01928582672223E-4;0.7800242071602487;[NRP1]
GO:1902378;VEGF-activated neuropilin signaling pathway involved in axon guidance;10.0;1.0;0.9152410118609203;9.628524252492122;58.60337150540505;9.777073627680469;0.0019614021046756975;0.9152410118609203;[NRP1]
GO:0003198;epithelial to mesenchymal transition involved in endocardial cushion formation;7.0;1.0;0.8509193652572005;9.628524252492122;26.141399598032546;7.379178354882098;8.749291188139309E-4;0.728290889492758;[TMEM100, ENG]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[CHRM2, FMR1, TNF, PYCARD, STMN1, IFNA14, IFNA16, RNASE6, RNASE2, IFNA10, GATA3, NLRP3, IFNA21, HMGA1, AZU1, DEFA1, CXCL10, IL6, CXCL12, PTPRC, SERINC5, IFNA5, CREBZF, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, CHUK, IFNGR1, IRAK3, MMP12, ACTA2, EEF1G, FGR, IFNG, PSMA2, TLR8, XCL1, TLR7, UNC93B1, CXCR4, SAMHD1, CCL8, CCL5, CCL4, CCL19, CCT5, CARD9, LILRB1, MAPK14]
GO:0009968;negative regulation of signal transduction;6.0;0.43649654099988644;0.5413685830900877;6.680044863788677;140.65047919891595;2.686163805600486;0.0047074449615745265;0.460490854527945;[, PID1, SLA2, PHB2, STMN1, AKT1, UBASH3A, PRKACB, PADI2, PRKCQ, ATF3, GATA3, ADAMTS12, FLRT2, FIGNL1, PRDM16, LYN, FZD1, EZH2, TGFB1I1, LRRC4, TIMP3, DUSP2, DUSP1, ARG1, FCRL3, PAWR, SIRT1, DUSP6, AES, MMP12, PXDN, LRRC19, PTGS2, FRZB, NR1H2, TMEM64, SULF2, LGR4, PF4, TNF, PYCARD, RUVBL2, MEN1, TLE4, CSF1R, LY96, FOXO1, WFS1, TNFRSF10B, PTPRE, CXCL12, PTPRC, BCL6, CCDC22, LRRK2, FASLG, PTPN22, HHEX, LBH, DUSP10, EMILIN1, PVRIG, CX3CR1, PPP1R15A, LRP1, LRP2, CCL5, FYN, CSK, CTHRC1, TIE1, PTPN6, LGALS3, PPP2R1A, EPHB1, IL1R2, PAQR3, MIF, RUNX2, SFRP4, SFRP2, SIK1, EPHA3, EPHA2, TWIST1, APCDD1, PKHD1, INPP5D, EGR1, LIF, VNN1, NRP1, PTPRR, ECM1, BRCA1, CD3E, RHOH, GP1BA, CEACAM1, BANK1, IL1B, KIT, TLR6, TLR4, YAP1, IFI6, GNAI2, PODN, NLRP12, GRINA, RGS1, PDGFRB, PDGFRA, TSC2, HGS, FBLN1, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, CAV2, CAV1, ARHGAP25, NR4A2, NFKBIA, IL6, BMP2, HMGB2, TNFAIP3, LRRTM4, NUP62, PTGIR, MYOCD, ARAP3, IRAK3, AXIN2, MMP9, DCN, DNM2, TGFBR3, NDUFS3, FBP1, PFDN5, LTF, BCL2A1, CLEC12B, TAF9, THBS1, EGF, MAPK14, TEK]
GO:0010955;negative regulation of protein processing;9.0;0.7192862368539868;0.7558837436072825;9.27570287786938;707.1969765737138;6.039404009397101;0.023669246369964203;0.705096027081865;[LRRK2, CTSZ, NLRC4, THBS1, CR1, IL1R2, GAS1, NAIP]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[PROS1, SPINT2, RPS6KA1, AKT1, POR, SFRP2, SPINT1, SLPI, NAIP, SFN, TNFSF14, TNFRSF10C, CRIM1, TNFRSF10B, DHCR24, SERPINA1, TIMP3, TIMP1, CR1, SERPINB9, TNFRSF1B, MMP9, PAX2, COL6A3, LTF, SERPINB10, IFI6, NLRC4, PTGS2, THBS1, SPOCK3]
GO:0060070;canonical Wnt signaling pathway;8.0;0.6729672293956388;0.7114836146978194;8.391761625343195;31.415129658942366;5.233778845410465;0.0010514361179036673;0.6426556935498979;[LRRK2, GATA3, CDH3, FRZB, SOX4, FZD1, FZD5, EGF, TMEM64, NR4A2, SFRP4, HOXB9, SFRP2, SDC1, LGR4]
GO:0030321;transepithelial chloride transport;8.0;1.0;0.875;9.628524252492122;29.941547406775403;8.16763571524637;0.001002116646061566;0.7926932703116032;[SLC12A2, P2RY6]
GO:0060071;Wnt signaling pathway, planar cell polarity pathway;9.0;0.7436939687323844;0.7680876095464813;9.094441766561864;99.0414819593438;5.825829909099042;0.0033148292696323837;0.694173837660411;[CELSR1, AP2M1, CTHRC1, FZD1, FZD5, VANGL1, SFRP2, PFN1]
GO:0031532;actin cytoskeleton reorganization;6.0;1.0;0.8231203125901445;9.628524252492122;32.01253927882412;5.788089581116195;0.001071430880247358;0.6191234829421188;[NRP1, ANTXR1, PAK1, FLNA, CXADR, ANXA1, GAB1, KIT]
GO:0060177;regulation of angiotensin metabolic process;6.0;1.0;0.8231203125901445;9.628524252492122;43.97722126997476;9.083926447120524;0.001471878018976464;0.7876727335416686;[SUCNR1, ACE]
GO:0019408;dolichol biosynthetic process;8.0;1.0;0.875;9.628524252492122;352.4236781976971;9.083926447120524;0.011795303348558361;0.839552420951524;[SRD5A3]
GO:1903597;negative regulation of gap junction assembly;7.0;1.0;0.8509193652572005;9.628524252492122;107.40702245958384;9.777073627680469;0.003594816381677759;0.8509193652572005;[ACE]
GO:1900086;positive regulation of peptidyl-tyrosine autophosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;1786.9389585583017;8.16763571524637;0.05980723880229299;0.8501222226412654;[ACE, SYK]
GO:0008654;phospholipid biosynthetic process;6.0;0.6073376606709605;0.6267891429256247;8.318602870156806;240.3742781336296;4.22799754278525;0.008045110766327128;0.5393403035501751;[FGF5, INPP5D, SRD5A3, BMX, SERINC5, SLC44A5, SLC44A1, GAB1, SGMS1, AGPAT3, MBOAT7, MBOAT2, LPCAT2, NDUFAB1]
GO:0007200;phospholipase C-activating G-protein coupled receptor signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.976932752798508;5.288437257948329;9.028936615729279E-4;0.5935712398991049;[CHRM2, LHCGR, CHRM1, C5AR1, F2R, FPR1, FPR3, FPR2, GPR84, NMBR, MC3R, GRM5, P2RY6, EDNRB, P2RY2, CXCR2, C3AR1, AGTR1, F2RL3]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[CXCL13, SLC8A1, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, PDGFRA, F2R, ADCYAP1, AGTR1, CALCA, C5AR1, FPR1, FPR3, FPR2, CD19, HRH4, PLCG1, CCR10, CCR1, CAV1, CXCL10, CXCL11, PTPRC, CD24, GPR18, CXCL9, FASLG, JPH2, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, CD52, PTGIR, TRPC3, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, S1PR3, CCL1, CCL19, GPR157, CCL21, GPR6, P2RX5, CD4, F2RL3]
GO:0030316;osteoclast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.375876246018314;0.0015755275618510598;0.6491829203200885;[CSF1R, TGFB1, FCER1G, TFRC, TREM2, TNFRSF11A, MAPK14, TNF, OSCAR, TNFSF11, EPHA2]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CX3CR1, CXCL6, CCL13, CXCL9, CXCR5, MPL, CXCR4, CXCL1, CXCR6, CXCL13, CXCL3, CXCL2, CXCL5, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCRL2, CCL4, CCR9, CCL2, CCL1, CCR7, CCR6, CCL19, CCR5, CCL18, CCR10, CCR2, CCR1, CCL23, CCL21, CCL20, PPBP, CXCL10, CXCL11, CXCL12, XCL1, PF4]
GO:0019532;oxalate transport;9.0;0.9326813400603323;0.8625812952104552;9.541512875502493;53.14108600855652;7.292166977892469;0.0017785843248339678;0.769162383550154;[SLC26A8, SLC26A7, SLC26A11, SLC26A3]
GO:0022408;negative regulation of cell-cell adhesion;6.0;0.5806842727486619;0.6134624489644754;7.765305819281922;52.92767189200162;4.7081694254602375;0.0017714415464131104;0.5638963159604501;[, CD86, CD80, IFNA2, PTPN22, SPINT2, LRRC32, LGALS3, CDH1, TNR, CTLA4, HAVCR2, LAG3, ANXA1, ARG1, PAWR, PDCD1LG2, CEACAM1, XCL1, PDE5A, CD274, EPB41L5, GPNMB, EPCAM, PAG1, TGFB1, JAG1, CCL21, LILRB1, LILRB2, PTK2, BMP2, CXCL12, BCL6, CD9, PTPN6, FCGR2B]
GO:0090331;negative regulation of platelet aggregation;10.0;0.9326813400603323;0.8815816818910864;9.601125278304007;548.6740902153413;7.379178354882098;0.01836362802488484;0.7926125360964777;[CEACAM1, CD9]
GO:0009435;NAD biosynthetic process;11.0;0.7980440201809971;0.8314509624201607;9.500690880982237;2002.0309936558642;5.825829909099042;0.06700617564674446;0.730362164809784;[PTGS2, HK3, KMO]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD86, CD80, SLA2, FGF5, IMPA2, PDGFRB, PDGFRA, GAB1, TTC7B, VAV1, EREG, BTC, LCK, KIT, HBEGF, CD19, FYN, ICOS, TRAT1, EGF, KITLG, CD28]
GO:0045765;regulation of angiogenesis;6.0;0.7043150770688792;0.675277851124584;8.817594036275793;44.93985318205118;4.1639455212923995;0.0015040964427611868;0.5360646801923071;[PLXND1, CXCL13, CDH5, C3AR1, PROK2, CYP1B1, HOXA5, GHSR, HSPG2, SFRP2, HGS, ADAM12, AGTR1, EPHA2, C5AR1, TWIST1, PLCG1, TGFB2, JUP, PLK2, TNFSF12, CXCL10, IL6, ID1, NRP1, ECM1, CD40, TNFAIP3, FASLG, PRL, BRCA1, HHEX, STAB1, CTSH, ITGB8, EMILIN1, CD34, CCR2, ANXA1, ANXA3, GAB1, SIRT1, DCN, CEACAM1, IL1B, CHI3L1, ENG, CX3CR1, PTGS2, DLL1, THBS1, GPNMB, CXCR2, E2F2, TIE1, LRG1, TEK, PF4]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[PHB2, TNF, PYCARD, AKT1, TNFSF11, BTK, PRKCQ, S100A8, CARD11, BEX1, TNFRSF11A, NHLH2, NLRP3, FZD1, TGFB1, JUP, NFKB1, IL6, COPS5, JMY, MYD88, CD40, CD36, MYOCD, CHUK, ANXA3, NFAM1, IRAK3, TRAF1, PSMA6, IL1B, KIT, TLR6, TLR4, LTF, TLR2, NLRC4, CD40LG]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, BRCA1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, GHSR, ANXA1, ANXA3, GAB1, SIRT1, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, CXCR2, PLCG1, JUP, PLK2, TNFSF12, LRG1, TEK]
GO:0045404;positive regulation of interleukin-4 biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.083926447120524;0.027900220892599446;0.839552420951524;[CD86]
GO:0051088;PMA-inducible membrane protein ectodomain proteolysis;8.0;1.0;0.875;9.628524252492122;51.441664339349536;8.67846133901236;0.0017217062109458165;0.8188169164668168;[ADAM9]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[SPI1, EHMT2, SLA2, PHB2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, PRDM16, ELANE, FZD1, JUN, PKIG, EZH2, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, BTAF1, FLNA, NR1H2, LGR4, GMNN, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, EMILIN1, RFC1, PEG3, XCL1, RBBP8, E2F1, E2F7, PRRX1, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, DPF3, SOX4, RUNX2, EREG, SFRP2, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, IFNA2, PTPRK, BRCA1, XPO1, CD36, CBFA2T3, MDFIC, IL1B, ARID4A, LOXL2, CHCHD3, BASP1, CCNE1, CALCA, TGFB1, CBX4, CAV1, HMGA1, NR4A2, BMP2, NR4A3, MXD1, CREBZF, HMGB2, MYOCD, IFNG, ELF3, FBP1, PFDN5, MEIS2]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, JUN, JAG1, JUP, COL1A1, HOXC10, FOS, SIRT1, MMP12, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, RUVBL2, ADCYAP1, BLM, FOXO1, NFKB1, CXCL10, CIITA, HHEX, PPP1R12A, PEG3, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, CCNH, TNFSF11, SFRP2, EGR1, EGR2, EGR3, CD28, CD40, BRCA1, BRCA2, CD3D, RGMA, IL1B, YAP1, IL17A, CD86, CD80, CCNE1, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, NUP62, MYOCD, CCNA2, PSRC1, ELF3, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, TGFB1I1, PAX5, PAX2, ENG, EPCAM, NR1H2, GTF2H1, PF4, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, COPS5, MAFF, CYR61, LBH, EMILIN1, RFC1, CHUK, SMARCD3, CEBPE, ABLIM3, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, TWIST1, NHLH2, BCL11B, LIF, IFNA2, PRL, RHOG, MDFIC, TLR4, TLR2, LILRB1, GRHL2, CAMK4, ARID4A, ARID4B, HOXA11, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, CKAP2, DCN, DNM2, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:0016095;polyprenol catabolic process;7.0;0.8933024483968273;0.7975705894556142;9.541512875502493;320.2501318467851;8.67846133901236;0.01071848370650518;0.7947362817240173;[SRD5A3]
GO:0001947;heart looping;7.0;1.0;0.8509193652572005;9.628524252492122;47.98143023837329;5.71663061713405;0.001605895289594654;0.6432681208679463;[DLL1, MEF2C, ENG]
GO:1903082;positive regulation of C-C chemokine receptor CCR7 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;365.88844033500624;9.777073627680469;0.01224595681979491;0.896240625180289;[TREM2]
GO:0071805;potassium ion transmembrane transport;9.0;0.8259837884571596;0.8092325194088689;9.456673995565463;120.6235085317852;4.695669262696007;0.004037160276449102;0.636377369645515;[KCNK5, KCNG2, KCNE3, KCNE4, SLC1A3, KCNA5, KCNMB3, KCNN3, KCNH1, SLC12A2, KCND2, SLC12A1, KCNJ15, KCNJ16, ATP1B2, ATP1B1, KCNQ1]
GO:0008595;anterior/posterior axis specification, embryo;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;40.32465619079058;7.697632086000634;0.0013496299528713244;0.6838982747154925;[FZD5, PCSK6]
GO:0007268;chemical synaptic transmission;7.0;0.7369933605727446;0.7194160455435727;8.663443356448536;23.173347188538074;3.922001705478042;7.755910757418987E-4;0.5514907148670789;[CHRM2, GABRB1, CHRM1, GRIK3, GRM5, CHRNB4, KCND2, NPY1R, SLC5A7, SLC1A3, SLC1A6, GJC1, SV2A, NPY, HRH4, KCNMB3, SLC17A6, GABRE, DRD4, EGR3, HTR1E, GABRA5, PCDHB15, PCDHB14, PCDHB10, P2RX1, PNOC, PCDHB16, PLP1, PMP22, PCDHB4, PCDHB8, GPR19]
GO:0009449;gamma-aminobutyric acid biosynthetic process;8.0;1.0;0.875;9.628524252492122;747.1446474653511;8.67846133901236;0.025006258964137613;0.8188169164668168;[SLC1A3]
GO:0001953;negative regulation of cell-matrix adhesion;7.0;0.8653626801206646;0.7836007053175329;9.387362195675234;66.9585131603638;6.280566066213989;0.002241041176727861;0.6721078059595746;[JAG1, ARHGAP6, THBS1, BCL6, HOXA7]
GO:0031581;hemidesmosome assembly;6.0;1.0;0.8231203125901445;9.628524252492122;36.796901128588246;7.292166977892469;0.0012315591657128446;0.6960420709600095;[CD151, LAMB3, ITGB4, LAMA3, LAMC2, LAMC1]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, FCER1G, CHUK, SYK, FOS, VAV1, LAT2, BTK, PRKCQ, LCP2, CARD11, PAK1, IGKC, IGLV1-44, PLCG1, LYN, JUN, NFKB1, NR4A3, IGKV3-20, LAT]
GO:0008203;cholesterol metabolic process;6.0;0.7980440201809971;0.722142322680643;9.223059144383958;82.64786032185484;5.058574756385375;0.0027661495067272364;0.581816060879476;[CUBN, CH25H, CFTR, ABCA1, DHCR24]
GO:0045665;negative regulation of neuron differentiation;8.0;0.6162540371078848;0.6831270185539424;8.732436227935485;338.1488864638422;4.401795219996305;0.011317538915704735;0.6001080122550225;[SEMA5B, EDNRB, ARHGDIA, TNR, HOXA2, PAQR3, JAG1, PLK2, PTK2, ID1, ITM2C, NRP1, LRRK2, CTSZ, ARHGAP4, DCC, RGMA, IL1B, NLGN1, LRP1, DLL1, LINGO1, SEMA4B, MEIS1, PMP22]
GO:0044332;Wnt signaling pathway involved in dorsal/ventral axis specification;8.0;1.0;0.875;9.628524252492122;31.415129658942366;7.9853141584524145;0.0010514361179036673;0.7833693374183408;[FZD5, EGF]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[CYR61, IL6R, CTHRC1, MEF2C, JAG1, RUNX2, IL6, BMP2, SFRP2, LTF]
GO:0044339;canonical Wnt signaling pathway involved in osteoblast differentiation;9.0;1.0;0.896240625180289;9.628524252492122;34.305501416841174;8.67846133901236;0.0011481742594748403;0.8400575416471059;[FZD1, TMEM64]
GO:0044338;canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation;9.0;1.0;0.896240625180289;9.628524252492122;34.305501416841174;9.083926447120524;0.0011481742594748403;0.8607930461318132;[FZD1]
GO:0009414;response to water deprivation;5.0;0.8436909121759173;0.712086467948879;9.427853557029971;59.73918226934355;7.697632086000634;0.001999416668781396;0.6838982747154925;[CD9, AVPR1A, SIPA1, LRP11]
GO:0030007;cellular potassium ion homeostasis;9.0;0.9326813400603323;0.8625812952104552;9.574457031221845;285.76071857591336;7.138016298065211;0.009564154082785858;0.7612791106150483;[ATP1B2, ATP1B1]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, CTGF, ADAMTS1, ITGAX, ITGB8, ITGB6, FCER1G, SYK, VAV1, FGR, HCK, CEACAM1, ADAM9, ITGA7, TLN1, PTK2, ZYX, PLP1, LAT]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, FPR1, GATA3, FLRT2, HLA-DQA2, HLA-DQA1, HLA-DRB4, HLA-DRB1, CDKN1A, LRRC4, TIMP1, HLA-DPA1, ANXA1, IFNGR1, FOS, SIRT1, FCER2, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, HLA-DPB1, PF4, CSF3R, F13A1, IL5RA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IL13RA1, IFNA14, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL1, CX3CR1, IL2RG, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, IL2RB, PTPN6, TNFSF11, ACSL1, IL1R1, IL1R2, FLT3LG, MIF, EREG, IFI27, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, SYK, GP1BA, IL17RB, VAV1, HCK, CEACAM1, IL1B, KIT, RHOU, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR2, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, TGFB1, NFKBIA, IL6, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, GHR, LRRTM4, IRAK3, MMP9, DCN, IFNG, LTA, SAMHD1, NCAM1, CD4, LTBR]
GO:0060828;regulation of canonical Wnt signaling pathway;7.0;0.6954798709641801;0.6986593007392905;8.83001655627435;44.04846258837617;4.37439624580819;0.0014742624017903352;0.5746261926980603;[RUVBL2, RUVBL1, SOX4, TLE4, SFRP4, SFRP2, DAAM2, NAIP, FOXO1, FZD1, EGR1, JUP, FZD5, CAV1, NFKB1, COL1A1, BMP2, CDK14, LRRK2, AXIN2, AES, PFDN5, YAP1, FRZB, CTHRC1, EGF, TMEM64, MAPK14, PPP1CA, SULF2, LGR4]
GO:0043252;sodium-independent organic anion transport;7.0;1.0;0.8509193652572005;9.628524252492122;31.887457555831563;6.444869117505266;0.0010672445075450394;0.6805102716434839;[SLCO2B1, SLCO4C1, SLCO5A1]
GO:0010633;negative regulation of epithelial cell migration;8.0;0.7980440201809971;0.7740220100904985;9.427853557029971;243.45111910585655;5.602686357784832;0.008148089864690466;0.6615216408886768;[PTPRR, TACSTD2, CXCL13, THBS1, DUSP10, MEF2C, TGFB1, JUP, DCN]
GO:0033630;positive regulation of cell adhesion mediated by integrin;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.61675044652454;6.943860283624253;0.0011585914843924019;0.6453503496879909;[TGFB2, SFRP2, SYK, CCL21, CCL5, ADAM9, NCKAP1L, PTPN6, CXCL13]
GO:2000810;regulation of bicellular tight junction assembly;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;28.92769022108224;6.781341354126479;9.681837584686441E-4;0.6699184248047958;[FZD5, GPBAR1, TNF]
GO:0086064;cell communication by electrical coupling involved in cardiac conduction;4.0;0.8259837884571596;0.6629918942285797;8.935377071932177;22.009319849728328;7.138016298065211;7.366321282685284E-4;0.6150384854347593;[GJC1, ATP1B2, ATP1B1, SLC8A1]
GO:0019229;regulation of vasoconstriction;7.0;0.7369933605727446;0.7194160455435727;9.310070521373587;55.827436365827396;5.500407508664414;0.0018684940537334635;0.6322104610454062;[DOCK5, CHRM1, PTAFR, KCNA5, PTGS2, AKT1, ACE, CAV1, F2R, AVPR1A, P2RX1, AGTR1]
GO:0032781;positive regulation of ATPase activity;6.0;0.7508913569872202;0.6985659910837546;8.781226392104918;51.416896668601964;5.8067817141283475;0.0017208772592953517;0.6200793994936333;[TPM1, ATP1B2, ATP1B1, DNM2, PFN1]
GO:0043017;positive regulation of lymphotoxin A biosynthetic process;8.0;1.0;0.875;9.628524252492122;856.0759792352393;9.777073627680469;0.028652092606641942;0.875;[CD86]
GO:0097084;vascular smooth muscle cell development;5.0;0.8933024483968273;0.736892236059334;9.4949928598676;32.84635378887841;7.697632086000634;0.001099337901514535;0.6838982747154925;[ENG]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[, PHB2, AKT1, PROK2, PRKACB, PRKAR1B, FPR1, FPR2, SLC30A10, IQGAP3, PRKAR2B, PDGFD, PDGFC, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, CDC6, AZU1, NOX4, EZH2, CDKN1A, HAVCR2, GPR37, FCRL3, SIRT1, DUSP6, HBEGF, ENG, CCL13, PTGS2, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, PKN1, CCNT2, FMR1, TNF, CTGF, PYCARD, IFNA14, MAP2K2, IFNA16, F2R, ADCYAP1, ADAM9, IFNA10, CSF1R, TNFRSF11A, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, PTPRC, CSPG4, LAT, LRRK2, ITGB3, TREM2, PTPN22, CYR61, XCL1, LCP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, RAD50, FCGR2B, CCNH, TCL1A, EDNRB, TNFSF11, EPHB1, ACSL1, SLC11A1, FLT3LG, MIF, EREG, SFRP2, EPHA3, EPHA2, TGFA, CCR1, EGR1, LIF, PTK2, MARCO, CD24, IFNA5, IFNA4, NRP1, IFNA7, CD40, IFNA2, CD3E, IFNA8, CCR7, CD36, MAP4K1, SYK, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CXCR4, GNAI2, PAK1, CD40LG, CD80, IL6R, PDGFRB, PDGFRA, CALCA, C5AR1, ADRB2, STAP1, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, GHR, GRM5, AXIN2, MMP9, PSRC1, IFNG, CHI3L1, PDE5A, LTF, THBS1, EGF, MAPK14, CD4, LTBR, TEK]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, PRTN3, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, CXCL10, CXCL11, IL6, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, CXCL1, SLC7A11, CXCL3, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, CCR6, CCR5, CD34, CCR2, ANXA1, FCER1G, SYK, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, IL1B, KIT, PECAM1, XCL1, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CCL23, CCL21, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[NRP1, NRP2, ECM1, ITGB3, HMGB2, AKT1, PLCG1, GHSR, JUN, EGR3, ARG1, CAV2, TNFSF12, SIRT1, NR4A1, BMP2, LRG1, CXCL12, AGTR1, TEK]
GO:0035924;cellular response to vascular endothelial growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;62.59148538135601;6.599019797332524;0.00209488068703431;0.6605944919115335;[NR4A1, NRP1, EGR3, ANXA1, AKT1, GAS1, MAPK14]
GO:0010882;regulation of cardiac muscle contraction by calcium ion signaling;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;68.46878113000767;6.641579411751319;0.0022915884865189126;0.7358913051622797;[PLN, DMD, ATP1B1, SLC8A1]
GO:0032495;response to muramyl dipeptide;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;59.66765988983927;7.004484905440688;0.0019970228791053504;0.6813299963962409;[JAG1, CARD9, TNFAIP3, PTPN22, MAPK14, NFKBIA]
GO:0061098;positive regulation of protein tyrosine kinase activity;11.0;0.8436909121759173;0.8542744084176208;9.55953138100517;2154.6219316186807;5.8650506222523235;0.07211325701743153;0.7323679139043926;[CSF1R, TGFA, GRM5, CCL5, STAP1, FYN, ACE, EGF, EREG, CD24]
GO:1903288;positive regulation of potassium ion import;10.0;1.0;0.9152410118609203;9.628524252492122;414.29394802332047;8.67846133901236;0.01386604559999416;0.8590579283277371;[ATP1B2, ATP1B1]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[ITGB5, PTPRK, F11R, CDH5, FOS, SIRT1, TGFBR3, ADAM9, JUN, TGFB2, TGFB1, USP9Y, PTK2, ID1, ZYX]
GO:0043542;endothelial cell migration;7.0;0.7980440201809971;0.7499413753476991;9.143016436710422;24.971868181253015;5.71663061713405;8.357859548042604E-4;0.6432681208679463;[NRP1, PLXND1, CXCL13, LOXL2, DPP4, CYP1B1, EGR3, TNFSF12, PTK2, NR4A1, ID1, S100P]
GO:0009597;detection of virus;6.0;1.0;0.8231203125901445;9.628524252492122;28.654098265158677;8.16763571524637;9.59026881920657E-4;0.7408135829017477;[SERINC5]
GO:0097052;L-kynurenine metabolic process;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;166.05137813699233;7.9853141584524145;0.0055575901897070516;0.8046099625986299;[KMO]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[F11R, LLGL2, EPHA2, RACGAP1, NCKAP1L, JUN, EZH2, ARHGAP9, DENND1B, NRP1, CD40, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL21, CCL20, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ADCYAP1, ACAP1, PRTN3, ARHGAP15, ADAP2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, LRRK2, TAGAP, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL1, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0045602;negative regulation of endothelial cell differentiation;7.0;0.8436909121759173;0.7727648213451592;9.503361109538115;205.47603111014118;7.697632086000634;0.006877097844834217;0.7445766281117727;[JAG1, ID1, S1PR3]
GO:0051044;positive regulation of membrane protein ectodomain proteolysis;9.0;1.0;0.896240625180289;9.628524252492122;964.0127980139503;7.069023426578259;0.03226464079433516;0.757750811958709;[IFNG, IL1B, ADAM9, TNFRSF1B, TNF]
GO:1903281;positive regulation of calcium:sodium antiporter activity;11.0;1.0;0.9324289523296623;9.628524252492122;1610.6520007917477;9.083926447120524;0.05390707297380812;0.8969813732811862;[ATP1B1]
GO:0032489;regulation of Cdc42 protein signal transduction;10.0;1.0;0.9152410118609203;9.628524252492122;50.14528765113853;7.8311634786251565;0.0016783176498546674;0.8157270763441555;[ABCA1, NRP1]
GO:0035754;B cell chemotaxis;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;95.76437754181396;7.9853141584524145;0.003205147533980157;0.7833693374183408;[CH25H, CXCL13]
GO:1903296;positive regulation of glutamate secretion, neurotransmission;10.0;0.9326813400603323;0.8815816818910864;9.604993755081928;1142.895349618749;8.67846133901236;0.03825167881270328;0.8590579283277371;[KMO]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRB, GPR171, C3AR1, AKT1, PROK2, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD5, OR2J2, AZU1, NMBR, PPBP, MARCO, PNOC, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, CD3E, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR2, GPR37, ANXA1, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, SPNS3, F2R, NPY1R, DGKZ, ADCYAP1, SPNS1, OR2C3, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, GPR84, ADRB2, GPR82, HRH4, PSAP, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, OR7E24, TAS2R7, CXCL6, CXCL9, OR1G1, CXCL1, CXCL3, CXCL2, CXCL5, GRM5, PDE4B, PTGIR, GLP2R, OR2H1, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0030182;neuron differentiation;4.0;0.5833093054345528;0.5416546527172764;7.212610474191073;21.066225782797595;4.296434704338478;7.050676185779127E-4;0.4697198705845162;[SOX4, MEF2C, RUNX2, CSF1R, FZD1, JAG1, BCL11B, FZD5, INHBA, USH2A, NR4A2, ID1, ITM2C]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, C3AR1, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, GNS, NCKAP1L, ELANE, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, ITGAM, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, PDCD1LG2, ZAP70, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, CD1D, CORO1A, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, LILRB2, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, CD28, HLA-DPB1, CD24]
GO:1990573;potassium ion import across plasma membrane;11.0;1.0;0.9324289523296623;9.628524252492122;262.9545538247555;7.57984905034425;0.008800852272780338;0.8200627852632958;[ATP1B1]
GO:0002726;positive regulation of T cell cytokine production;9.0;0.8933024483968273;0.8428918493787028;9.566003895510788;628.0492900660103;7.069023426578259;0.02102024453084469;0.757750811958709;[IL6, FZD5, NLRP3, XCL1, GATA3]
GO:0035745;T-helper 2 cell cytokine production;8.0;1.0;0.875;9.628524252492122;53.326986718937256;8.67846133901236;0.0017848062543106336;0.8188169164668168;[DENND1B]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, VSTM1, TNFSF11, MEF2C, IFNA14, IFNA16, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IFNA10, CALCA, TGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, IFNG, IL1B, LTA, XCL1, HBEGF, CCL13, NLGN1, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, CCL2, CCL1, CCL19, CCL18, CMTM8, CCL23, CCL21, EGF, CCL20, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, F11R, ANPEP, CLEC5A, ITGB6, HAVCR1, CTSB, CR2, CR1, CXADR, EPHA2, GYPA, DPP4, NCAM1, GPR15]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, EPS8, TPM1, VRK1, CSF1R, ARHGAP15, CORO1A, SPTA1, MYH14, PTK2, ANXA1, RHOG, ARAP3, RHOH, ARAP1, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD3, FGD4, CCL7, PDPN, CCL2, FYN, WASF3]
GO:0086013;membrane repolarization during cardiac muscle cell action potential;8.0;0.811012628672052;0.780506314336026;9.249034630787218;81.641259119529;7.004484905440688;0.0027324594703676576;0.7332096838060964;[KCNQ1, KCNA5, ATP1B1]
GO:1905007;positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation;8.0;1.0;0.875;9.628524252492122;277.7728422204446;8.16763571524637;0.009296807049790315;0.7926932703116032;[TGFB2, ENG]
GO:0045747;positive regulation of Notch signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;187.6437959822434;5.926926025970411;0.006280268983073171;0.6540226378555745;[DLL1, TSPAN5, TGFB2, JAG1, ELF3, KIT]
GO:2000738;positive regulation of stem cell differentiation;6.0;0.7763722522362496;0.7113064387082693;9.193206181234276;114.95643040877245;6.832634648514029;0.003847488271711053;0.6725415662651573;[TGFB2, TACSTD2, HOXB4, LTBP3]
GO:0097028;dendritic cell differentiation;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;22.452520143917486;6.343086423195323;7.514656432606705E-4;0.6146267465268138;[LYN, TGFB1, SPI1, TREM2, LILRB1, CAMK4, PRTN3, CCR7, LTBR, CCL19]
GO:2000737;negative regulation of stem cell differentiation;6.0;0.7586651285174919;0.7024528768488905;9.136047767394327;115.31702415177813;6.781341354126479;0.0038595570197761534;0.6699184248047958;[YAP1, JAG1, LBH]
GO:0014911;positive regulation of smooth muscle cell migration;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;201.77833622021802;6.280566066213989;0.0067533393245778365;0.6961884407023742;[PDGFRB, DOCK5, NRP1, P2RY6, PAK1, NR4A3, CCL5, PDGFD, NOX4]
GO:0014910;regulation of smooth muscle cell migration;7.0;0.7866048967936545;0.7442218136540277;9.260799472366804;40.03709713961528;5.71663061713405;0.0013400056102148314;0.6432681208679463;[DOCK5, NRP1, LRP1, P2RY6, PAK1, CCL5, PDGFD, PDGFRB, MEF2C, MYOCD, ACE, TPM1, NR4A3, NOX4]
GO:0045639;positive regulation of myeloid cell differentiation;7.0;0.7307253602413294;0.7162820453778652;9.186691500213083;278.20784311065285;5.311165509025885;0.0093113661381102;0.622532616383239;[HMGB2, MPL, TNF, TNFSF11, HOXA5, FOS, IFNG, INPP5D, NCKAP1L, CCR1, JUN, JAG1, LIF, INHBA, TMEM64, MAPK14, CD4, ACIN1, PF4, IL17A]
GO:0007162;negative regulation of cell adhesion;5.0;0.5651597194614189;0.5728208715916296;7.400047131651798;38.26822196421712;4.255612709818223;0.001280802949978559;0.5078732437472537;[, CD86, PLXND1, CD80, TNC, SPINT2, LGALS3, CDH1, ARHGDIA, ARHGDIB, TNR, CYP1B1, HOXA7, MEN1, LAG3, ACTN4, CLDN7, CD274, TACSTD2, FBLN1, EPB41L5, PAG1, TGFB1, JAG1, PTK2, COL1A1, BMP2, CXCL12, PTPRC, BCL6, IFNA2, PTPN22, LRRC32, ARHGAP6, CTLA4, HAVCR2, ANXA1, ARG1, PAWR, PDCD1LG2, CEACAM1, XCL1, PDE5A, THBS1, GPNMB, EPCAM, JAM2, CCL21, LILRB1, LILRB2, CD9, PTPN6, FCGR2B, SIPA1]
GO:1903078;positive regulation of protein localization to plasma membrane;8.0;0.8436909121759173;0.7968454560879586;9.434368238051164;218.50214452761784;5.845247994956144;0.00731307013817619;0.6739262542938873;[LRP1, TREM2, AKT1, RHOG, SORBS1, IFNG, EPHA3, EPHA2]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB1, EREG, BTC, BTK, EPHA3, EPHA2, SDC2, TGFA, SLC30A10, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, PTK2, COL1A1, NRP1, ITK, PTPRR, NRP2, CD3E, SYK, GAB1, VAV1, HCK, KIT, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF2, NCF4, CTGF, FGF5, EFEMP1, GRAP2, AP2M1, PDGFRB, PDGFRA, TSC2, KIF16B, COL4A1, BLK, CSF1R, CUL5, RASGRP4, FOXO1, STAP1, TGFB1, CAV2, CRIM1, BMX, GH1, NR4A3, CSPG4, ITGB3, GHR, BLNK, MMP9, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, CD4, CD7, TEK]
GO:0045630;positive regulation of T-helper 2 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2538.1941708228874;7.8311634786251565;0.08495107467099283;0.8630410292508717;[CD86, NLRP3]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[, SLA2, F11R, TRBC1, C3AR1, AKT1, PRKACB, MEF2C, HHLA2, FPR1, FPR3, FPR2, GATA3, SLC30A10, KLRK1, PDGFD, PDGFC, LYN, ABCA1, JUN, JAG1, HLA-DRB4, VANGL1, COL1A1, HLA-DRB1, SIGLEC9, LRRC4, CTLA4, HLA-DPA1, PTH2R, FOS, SIRT1, LRRC19, PTAFR, KCNA5, PTGS2, FRZB, NTF3, STAT4, FLNA, IL12RB1, IL12RB2, P2RY13, P2RY14, USP9Y, TMEM64, HLA-DPB1, LGR4, NCF4, F13A1, CXCL13, CTGF, EFEMP1, AP2M1, LAG3, IFNA14, IFNA16, IFNA10, BLK, CD274, GPR87, TACSTD2, LY96, TNFRSF11A, CORO1A, FOXO1, TNFRSF17, IFNA21, GRIA4, GPR98, TNFRSF10C, TNFRSF10B, BMX, NFKB1, CXCL10, CXCL11, CXCL12, PTPRC, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, ITGB5, ITGB4, LRRK2, ITGB3, FASLG, TNFSF13B, HHEX, FCGR3A, ITGAX, ITGB8, ITGB6, TNFRSF1B, ITGA7, LCP2, IL2RG, TSPAN33, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, CTHRC1, TSPAN15, TSPAN13, FCGR2A, IL2RB, PTPN6, CD247, FCGR2B, ICAM2, TNFSF11, EPHB1, MIF, EREG, BTC, SFRP4, SFRP2, IFI27, BTK, EPHA3, EPHA2, SDC2, TGFA, CD19, TSPAN5, TSPAN2, PAG1, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, PPBP, PTK2, ID1, CD28, SDC1, CD24, IGHM, NRP1, PTPRR, NRP2, CD40, TNFRSF13B, GRIK3, CD3G, PTPRK, CD3E, CD3D, CCR9, FCER1A, CD37, CCR7, CCR6, MUC15, CD36, CCR5, CCR2, FCER1G, SYK, GAB1, RGMA, LAT2, IL1B, KIT, IGHD, GNAI2, PAK1, IGKC, SORT1, IL18R1, IL17A, CD86, CD80, TRAC, MPL, CELSR1, CCRL2, IL6R, PDGFRB, CD97, PDGFRA, THEMIS, GEM, OSCAR, CCNE1, CARD11, PSEN2, KIR2DL1, RASGRP4, CAV2, CRIM1, INHBA, GH1, IL6, BMP2, IGKV3-20, SIRPB1, GHR, GRM5, NUP62, IRAK3, MMP9, BCL2A1, SAMHD1, EGF, MAPK14, CD2, CD4, CD6, CD7, CD9, TEK, CDA, CYFIP1, CLEC10A, EPS8, STMN1, GPR171, HOXB9, DAAM2, PRKCQ, FLRT2, NCKAP1L, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, FZD1, FZD5, GP6, CDK14, DENND1B, ITK, CDKN1A, TGFB1I1, ASGR2, TIMP1, ANXA1, IFNGR1, NFAM1, AES, FCER2, HBEGF, ENG, HLA-DQB1, CCL13, ALOX5, CCL19, CCL18, GPR157, CCL23, CCL21, CCL20, CARD9, G0S2, SULF2, ZYX, PLP1, PF4, SEMA5B, CSF3R, PLXND1, FMR1, ITGA2B, IL5RA, TNF, FGF5, PYCARD, CDH5, IGHG1, CDH3, FCGRT, GRAP2, IL13RA2, IL13RA1, TLE4, CLEC4D, ADAM9, CSF1R, CD151, CALCRL, CUL5, IGLV1-44, EIF2B3, BCL6, CSPG4, LAT, PTPN22, ADAMTS1, CR2, CR1, CHUK, LCK, ESRP1, IL3RA, XCL1, CX3CR1, P2RY6, PLN, P2RY2, POLR2E, CSK, POLR2I, POLR2J, POLR2K, POLR2L, SEMA4B, P2RX5, P2RX1, MNDA, CLEC2D, EDNRB, ICOSLG, SOX4, ACSL1, IL1R1, IL1R2, FLT3LG, RUNX2, TLN1, PFN1, IGSF6, TWIST1, APCDD1, CD79B, CD79A, INPP5D, CCR10, LIF, NMBR, MARCO, IFNA5, ROBO2, IFNA4, IFNA7, IFNA2, PRL, IFNA8, FFAR2, GP1BB, GPBAR1, GP1BA, PDCD1LG2, LIME1, IL17RB, VAV1, HCK, CEACAM1, RHOU, TLR4, TLR2, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR2, LILRB1, LILRB2, SORBS1, LILRB3, PODN, KRT19, CD40LG, IL18RAP, ARHGDIA, TSC2, KIF16B, COL4A1, KLRF1, PRTN3, KLRB1, C5AR1, CSF2RB, ADRB2, STAP1, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A3, KLRD1, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, TMEM100, LRRTM4, BLNK, PDE4B, DCC, GLP2R, AXIN2, DCN, TGFBR3, FGR, ZAP70, IFNG, LTA, CLEC12B, DLL1, REPS2, S1PR3, NCAM1, TRAT1, TSHR, LTBR]
GO:0042491;inner ear auditory receptor cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;103.53578895689377;7.9853141584524145;0.003465249680226682;0.7592887026755414;[JAG1]
GO:0042130;negative regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;581.9323154417883;5.734022359845919;0.01947675089275457;0.6894787953221185;[CD86, CD274, CD80, LRRC32, GPNMB, CTLA4, HAVCR2, TGFB1, ARG1, PAWR, LILRB1, PDCD1LG2, LILRB2, XCL1, PTPN6, PDE5A]
GO:0035729;cellular response to hepatocyte growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;78.10713999468214;7.138016298065211;0.00261417568375975;0.6881587980249038;[NRP1]
GO:0071902;positive regulation of protein serine/threonine kinase activity;11.0;0.6763753087927167;0.7706166067260205;9.206529842432747;1260.5827351979337;3.9422628906178643;0.04219056969626795;0.6340364598898325;[, CCNH, TCL1A, AKT1, PROK2, TNFSF11, ACSL1, MIF, FPR1, TGFA, IQGAP3, PDGFD, PDGFC, ELANE, FZD5, CDC6, NOX4, CD24, EZH2, CD40, MAP4K1, SYK, SIRT1, DUSP6, MDFIC, IL1B, KIT, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD40LG, PKN1, CCNT2, TNF, PDGFRB, MAP2K2, F2R, ADAM9, CSF1R, C5AR1, TNFRSF11A, ADRB2, DRD4, MAP2K6, TGFB1, GH1, BMP2, CSPG4, LRRK2, GHR, PSRC1, IFNG, PDE5A, LTF, THBS1, CSK, EGF, MAPK14]
GO:0032456;endocytic recycling;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;48.979792040619635;6.409777797693995;0.0016393095606485504;0.6509166472493662;[DENND1B]
GO:0090179;planar cell polarity pathway involved in neural tube closure;10.0;1.0;0.9152410118609203;9.628524252492122;275.5135961891709;7.212124270218933;0.009221192118313007;0.7840693824379941;[FZD1, SFRP2, CELSR1]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[ORM1, FZD5, PYCARD, NLRP12, TLR8, NLRP3, CCL19, TLR4]
GO:0045124;regulation of bone resorption;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;23.47587490287836;6.139487467954083;7.857164060836016E-4;0.6370939872166814;[CSF1R, CALCA, TFRC, SYK, ITGB3, TNFAIP3, TNFRSF11A, TMEM64, IL6, INPP5D, TNFSF11, CSK]
GO:0022009;central nervous system vasculogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;8.390779266560578;7.282666309192915E-4;0.7193458537639684;[ENG]
GO:0090050;positive regulation of cell migration involved in sprouting angiogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;645.2358217485536;6.7325511899570465;0.021595462279385098;0.7767319332797141;[NRP1, ANXA1, PLK2, PTGS2]
GO:0001300;chronological cell aging;4.0;1.0;0.75;9.628524252492122;26.138269705024182;9.083926447120524;8.748243641116619E-4;0.714552420951524;[ENG]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, PHB2, SLC8A1, LOXL2, MYB, AKT1, ACTN4, ATP1B1, CLDN3, ABCB4, PSEN2, TWIST1, DPP4, EGR1, TGFB2, TGFB1, CAV1, NR4A2, BMP2, CXCL12, NOX4, CD24, ALAD, MYOCD, ADSL, KCND2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, CCNA2, IL1B, LTA, TLR2, CXCR4, KCNA5, PTGS2, THBS1, PAK1, E2F1, TEK]
GO:0071773;cellular response to BMP stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.280566066213989;0.003262744749111514;0.6443087532925187;[TMEM100, BMP2, SPINT1, SPINT2, GATA3, ADAMTS12, RUNX2]
GO:0031077;post-embryonic camera-type eye development;7.0;1.0;0.8509193652572005;9.628524252492122;36.784493016758105;8.390779266560578;0.0012311438773764656;0.7800242071602487;[BCL11B, FZD5]
GO:0015825;L-serine transport;11.0;0.8933024483968273;0.8790801765280758;9.510741216835738;156.85333935075835;7.474488534686424;0.005249740109229274;0.8146746435927894;[SERINC5]
GO:0050714;positive regulation of protein secretion;8.0;0.6467165523344657;0.6983582761672329;8.730582659286164;381.48337166918856;4.304802954008995;0.01276790513702299;0.5951478232618299;[TNF, PYCARD, CLEC5A, SOX4, F2R, GOLPH3L, MIF, ADAM9, CFTR, BLK, CD274, CSF1R, TWIST1, GATA3, NLRP3, TGFB2, TGFB1, FZD5, IL6, ORM1, LRRK2, PTPN22, FFAR2, CD34, HAVCR2, CHUK, SYK, IL17RB, MMP12, TLR1, FGR, IL1B, IGHD, TLR8, TLR4, TLR2, CD58, CCL19, NR1H2, MAPK14, CD2, NLRP12, CD244, IL17A]
GO:0015701;bicarbonate transport;7.0;1.0;0.8509193652572005;9.628524252492122;31.887457555831563;6.015873511986907;0.0010672445075450394;0.6585714164269392;[SLC4A3, SLC4A7, CA4, SLC26A8, SLC26A7, SLC26A11, SLC26A3, CFTR]
GO:0050712;negative regulation of interleukin-1 alpha secretion;11.0;1.0;0.9324289523296623;9.628524252492122;999.3037873052855;9.777073627680469;0.033445798446087804;0.9324289523296623;[IL1R2]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, FPR2, GATA3, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, ARHGAP6, ARHGAP4, DUSP1, GMIP, SIRT1, DUSP6, PTAFR, STAT4, DMD, PKN1, LGR4, CTGF, KCNH1, MSH6, ADCYAP1, MSH2, BLK, LY96, TNFRSF10B, BMX, CORO2A, NFKB1, LRRK2, TNFRSF1B, LCP2, PPP1R15A, IL2RG, CCL5, E2F1, CCL2, E2F2, FYN, E2F7, SH2B1, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, EREG, BTC, BTK, EPHA2, RACGAP1, PAG1, CCR1, PTK2, RGL4, CD24, RGL1, CD40, BRCA1, BRCA2, CCR9, RAC2, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR2, LAT2, MC3R, IL1B, KIT, YAP1, PCNA, GNAI2, PAK1, KITLG, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, PDGFRA, DOK3, CARD11, CALCA, PSEN2, RASGRP4, SPTA1, GH1, TNFAIP3, GHR, GRM5, IRAK3, CCNA2, NDUFS4, BCL2A1, EPS8L1, EGF, MAPK14, TEK, CYFIP1, EPS8, STMN1, CYP1B1, ADCY9, LGALS12, PRKCQ, PLCG1, PLK2, ITK, CDKN1A, NFAM1, PAX2, CIT, HBEGF, GSN, CCL20, CARD9, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, DGKZ, NRBP1, RAB32, MELK, CSF1R, CALCRL, CUL5, MAP2K6, DHCR24, BCL6, CNOT3, CSPG4, LAT, TREM1, CHUK, IL3RA, CX3CR1, RAB21, PLN, DNAJA3, EDNRB, PPP2R1A, CHEK1, RPS6KA1, SOX4, PTGDR, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, RHOG, RHOH, AVPR1A, VAV1, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, PDPN, MLH1, CAMK4, SIPA1, SIRPG, ARHGDIA, ARHGDIB, TSC2, ATP1B1, CSF2RB, ADRB2, TGFB1, SELE, NFKBIA, ARHGAP30, JMY, DOCK5, MCTP1, CXCL1, TMEM100, BLNK, PTGIR, TGFBR3, ZAP70, NCAM1, TSHR]
GO:0055065;metal ion homeostasis;7.0;0.5744162724172468;0.6381275014658239;7.901303304401638;34.207534478055855;3.4003466797818422;0.0011448953941982165;0.5248132525935356;[TFRC, EDNRB, C3AR1, PROK2, TNFSF11, PTGDR, SLC11A1, AGTR1, FPR1, TMTC2, FPR3, FPR2, PKHD1, CD19, S100A14, PLCG1, ELANE, CCR10, CCR1, CYP4F2, SFXN3, CD24, GPR18, CD40, JPH2, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, CD52, AVPR1A, MC3R, SLC7A8, IL1B, CAPS2, CCL13, PTGER2, CXCR5, CXCR4, KCNA5, CXCR6, CXCR1, CXCR2, CCL19, GPR157, CCL23, CCL21, SLC31A2, TMEM64, GPR6, GRINA, F2RL3, STEAP4, CXCL13, SLC8A1, CCRL2, PDGFRA, F2R, ATP1B2, ATP1B1, ADCYAP1, CALCA, C5AR1, HRH4, DRD4, TGFB1, WFS1, CAV1, CYBRD1, CYP4F12, CXCL10, CXCL11, CXCL12, PTPRC, LCN2, CCDC22, CXCL9, ATP2A3, SLC40A1, FASLG, GRM5, ATP7B, HEPH, TRPC7, PTGIR, TRPC3, TRPC1, CYP4A11, LCK, XCL1, LTF, CX3CR1, SLC24A2, SLC24A1, SLC24A4, ATP2C2, CCL8, PLN, CCL7, SV2A, CCL5, S1PR3, CCL1, SLC12A2, SLC12A1, P2RX5, CD4]
GO:0034220;ion transmembrane transport;5.0;0.44800904580126355;0.514245534761552;6.183841758890227;26.332710660334534;2.96803432163749;8.813321279004005E-4;0.4420264250971726;[SLC35B3, AQP9, SLC4A3, PHB2, SCN1A, SLC6A16, SLC11A1, SLC6A15, CACNA2D3, SLC6A13, CLDN4, COX7A2L, KCNQ1, CFTR, SLC22A4, TTYH3, TTYH2, ATP5J, ATP5I, ATP5H, SLC30A10, ATP5O, ATP5L, GJC1, ANKH, KCNMB3, KCNN3, SCN3A, ABCA1, SLC6A6, SFXN3, FXYD6, GABRB1, COX7B, GRIK3, SLC7A11, COX7C, JPH2, CCR7, CCR5, COX8A, KCND2, ZDHHC17, TMEM37, SLC7A5, SLC7A7, SLC7A8, CLDN17, SGK1, CAPS2, SLC43A2, KCNA5, COX5B, COX5A, ANO10, SLC17A6, CCL19, GABRE, SLC17A3, CCL21, SLC31A2, GABRA5, COX6C, KCNG2, STEAP4, ATP8A1, DENND5B, COX6A1, SLC8A1, SLC26A11, SLC16A3, KCNH1, CHRNB4, SLC38A1, F2R, ATP11C, ATP1B2, ATP1B1, ATP5J2, COX6B1, RHCE, KCNE3, CUL5, KCNE4, HVCN1, SLC41A2, SLC1A3, SLC38A11, CACNA1F, SLC1A6, SLC38A6, CYC1, CLCA4, GRIA4, PTPRC, SLC26A8, SLC26A7, SLC26A3, KCNK5, ATP2A3, SLC40A1, FASLG, ATP7B, SLC36A1, TRPC7, SLC13A1, TRPC3, TRPC1, NDUFS7, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, SLC3A1, LRP2, ATP2C2, SLC12A2, SLC35A3, NDUFA4, SLC12A1, KCNJ15, KCNJ16, SLC4A7, P2RX5, P2RX1]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[TNF, TNFSF11, FFAR2, CCR7, CCR2, FCER1G, IL17RB, IL1B, BTK, AGTR1, LTA, TLR10, TLR7, TLR6, TLR4, S100A8, TLR2, SUCNR1, TNFRSF11A, PTGS2, PLA2G7, CNR1, CCL4, CCL18, CCL23, NFKBIA, NLRP12, IL6, CD6, CD28, MYD88, IL17A]
GO:1902600;proton transmembrane transport;8.0;0.7586651285174919;0.754332564258746;9.117698628726131;95.86613314633948;4.835431205071165;0.0032085532024895276;0.6222841766978864;[COX7B, COX6A1, COX7C, SLC36A1, COX8A, ATP5J2, COX6B1, COX7A2L, NDUFS7, HVCN1, ATP5J, ATP5I, ATP5H, ATP5O, COX5B, COX5A, ATP5L, CYC1, NDUFA4, COX6C]
GO:0001676;long-chain fatty acid metabolic process;8.0;0.6835726970475526;0.7167863485237763;8.866384200445225;93.73125239075797;5.049685808968129;0.0031371006648681556;0.6332411671050352;[, CYP1B1, ACSL1, CYP4A11, ACSL5, ELOVL6, ACSBG1, SLC27A3, SLC27A2, HSD17B4, PTGS2, CYP3A4, ALOX5, PNPLA8, CYP4F2, CYP4F3, CYP4F12, TBXAS1, PLP1]
GO:0001558;regulation of cell growth;5.0;0.5833093054345528;0.5818956645781967;7.6590836060266145;26.25041167864861;3.793137346993279;8.785776550476476E-4;0.4842222321850823;[CDA, CYFIP1, CPNE5, KIAA1109, PPP2R1A, RPS6KA1, AKT1, SFRP2, MAP1B, AGTR1, PRKCQ, SFN, NRP1, CDKN1A, ARHGAP4, ESM1, AVPR1A, SIRT1, IL17RB, CEACAM1, SGK1, HBEGF, PAK1, FRZB, CDKN2C, SIPA1, SEMA5B, CTGF, CXCL16, TNR, S100A8, IGFBP7, TGFB2, TGFB1, SYT2, CRIM1, INHBA, CXCL12, BCL6, CYR61, TCHP, MYOCD, DCC, DNM2, PSRC1, NDUFS3, FBP1, TAF9, RAB21, SEMA4B]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[EDNRB, C3AR1, TNFSF11, IL1R1, IL1R2, BTK, AGTR1, GATA3, ADAMTS12, PLA2G7, CD19, ELANE, LYN, BST1, CD28, FFAR2, CCR7, CCR2, ANXA1, FCER1G, IL17RB, PSMA6, HCK, IL1B, TLR10, TLR7, TLR6, TLR4, TLR2, C1QA, PTGS2, NT5E, IGKC, CCL18, CCL23, NLRP12, ZYX, IL17A, PROS1, TNF, CDH5, IGHG1, GHSR, ADCYAP1, S100A8, SUCNR1, CALCRL, C5AR1, TNFRSF11A, IGLV1-44, NLRP3, SELE, NFKB1, NFKBIA, IL6, BCL6, IGKV3-20, MYD88, TNFAIP6, TNFAIP3, DUSP10, CR2, CR1, TNFRSF1B, LTA, XCL1, CNR1, CCL5, CCL4, MAPK14, CD6, TEK, FCGR2B]
GO:0034219;carbohydrate transmembrane transport;6.0;0.6260725219892441;0.6361565735847665;7.963516488903211;31.744356712186807;6.039404009397101;0.0010624550510906475;0.6319757144917204;[SORT1, SLC2A2, PPBP, SLC5A4, TMEM144]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[AQP9, AKT1, CYP1B1, MEF2C, KCNQ1, CFTR, ABCB4, ABCA1, EGR1, JUP, COL1A1, ID1, NOX4, EZH2, GABRB1, BRCA1, ANXA1, ARG1, IL1B, PTAFR, PTGS2, GNAI1, P2RY13, TNC, TNF, SLC8A1, CDH1, RUVBL2, ADCYAP1, BLM, FOXO1, OSBPL7, TGFB1, CAV1, INHBA, NFKB1, NFKBIA, BMP2, NR4A3, ALPL, SLC26A3, LRRK2, PDE4B, DNM2, CCNA2, COLEC12, P2RY6, CCL5, CCL2, RAD51, KLF5]
GO:0071404;cellular response to low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;7.004484905440688;0.0018993574991869968;0.6813299963962409;[ABCA1, FCER1G, SYK, CD9, CD36]
GO:0055072;iron ion homeostasis;9.0;0.811012628672052;0.801746939516315;9.292052015870908;38.23288616879122;5.395046993006588;0.0012796202927058053;0.6721435792979885;[STEAP4, TFRC, SLC40A1, HEPH, SLC11A1, LTF, CYBRD1, LCN2, SFXN3]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPINT2, PHB2, CYP1B1, EPHB1, SOX4, MEF2C, EREG, SFRP4, SFRP2, SPINT1, BTK, GATA3, INPP5D, SFN, LYN, JUN, BCL11B, FZD5, LIF, CDC6, NOX4, CDKN1A, TNFRSF13B, TGFB1I1, PRL, PTPRK, BRCA2, LRRC32, CTLA4, CD33, HAVCR2, DUSP1, ARG1, PAWR, PDCD1LG2, CBFA2T3, CEACAM1, IL1B, TLR2, PTGS2, PAK1, GPNMB, FRZB, PDPN, CCL23, CDKN2C, LILRB1, LILRB2, PODN, FABP7, PKN1, CD86, CD80, SIRPG, TNF, CDH5, DACH1, MEN1, F2R, TPM1, TSC2, ADCYAP1, HGS, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, BCL6, OGN, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, AXIN2, TGFBR3, IFNG, LTA, XCL1, PDE5A, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MEF2C, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, IQGAP3, PDGFD, PDGFC, NCKAP1L, PLCG1, ELANE, LYN, JUN, CDC6, CDKN1A, HOXC10, TIMP1, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, PAX2, MMP12, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, ITGB3, FASLG, CYR61, TNFSF13B, LBH, XCL1, CX3CR1, SMARCD3, LRP2, CCL5, E2F1, CTHRC1, PRRX1, KLF5, DNAJA3, PTPN6, TCL1A, EDNRB, SKP2, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, EREG, BTC, SFRP2, TGFA, TWIST1, CD1D, PKHD1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, PRL, CD3E, ESM1, RAC2, CTSH, CCR2, SYK, RHOG, PDCD1LG2, AVPR1A, HCK, CEACAM6, IL1B, KIT, YAP1, GNAI2, PAK1, CXCR2, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IL6R, PDGFRB, GHSR, PDGFRA, CCNE1, PRTN3, CARD11, C5AR1, LTBP3, DPP4, TGFB2, TGFB1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, GLP2R, MMP9, TGFBR3, CCNA2, ZAP70, IFNG, NDUFS4, LTA, LTF, DLL1, THBS1, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:0060301;positive regulation of cytokine activity;8.0;1.0;0.875;9.628524252492122;129.14918693253554;9.777073627680469;0.004322507059909803;0.875;[NRP1]
GO:0050850;positive regulation of calcium-mediated signaling;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;239.92176968958296;6.039404009397101;0.008029965715936047;0.6838554019015759;[TREM2, CD3E, TNF, JPH2, CCL4, SYK, TRAT1, ZAP70, P2RX5, CD4]
GO:0015808;L-alanine transport;11.0;0.8933024483968273;0.8790801765280758;9.567899630675686;156.4478742426539;7.8311634786251565;0.005236169556955925;0.8329150168128974;[SLC36A1]
GO:0034446;substrate adhesion-dependent cell spreading;6.0;1.0;0.8231203125901445;9.628524252492122;56.23121614310476;6.088194173566533;0.0018820081995007299;0.63447084575632;[NRP1, ITGB3, LAMB1, LAMC1, ANTXR1, TEK]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[TNC, CYR61, FBL, AKT1, MEF2C, TPM4, RUNX2, EPHA2, HSD17B4, TWIST1, GPNMB, FIGNL1, HSPE1, COL1A1, BMP2, PSMC2, ALPL, RBMX, LGR4]
GO:0015804;neutral amino acid transport;9.0;0.620063164412167;0.7062722073863725;8.558082840790709;67.63036776559719;6.113511981550823;0.002263527545735134;0.7088859122241795;[SLC36A1, SLC38A1, SLC43A2, SLC6A15, SLC3A1, SLC7A5, SLC7A8, SERINC5]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, GATA3, PAK1, INPP5D, FYN, CSK, PLCG1, HLA-DQA2, HLA-DQA1, PAG1, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, LAT, HLA-DRB1]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CD80, ITGB3, IFNA2, TREM2, CD3E, GHR, GRM5, CD36, IL6R, SYK, MIF, EREG, IFNG, BANK1, KIT, HBEGF, CSF1R, TGFA, CCL5, NTF3, STAP1, FYN, LYN, TGFB1, ACE, EGF, LIF, GH1, CD4, IL6, CSPG4, CD24]
GO:0071559;response to transforming growth factor beta;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;24.053434438352202;5.649939242635378;8.050468039660755E-4;0.5791791674783379;[CX3CR1, EPB41L5, PDGFD, FYN, MEN1, MEF2C, TGFB1, ARG1, CAV1, COL1A1, NOX4, XCL1, ENG]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD28, PTPN6, CD24, CARD11]
GO:0046488;phosphatidylinositol metabolic process;7.0;0.6835726970475526;0.6927057137809769;8.801845679307654;147.2037350013595;4.383446081328108;0.004926776535734991;0.5750890017074093;[CD86, CD80, SLA2, FGF5, PDGFRB, PDGFRA, TTC7B, EREG, BTC, CSF1R, CD19, INPP5D, ICOS, BMX, CD28, IMPA2, GAB1, VAV1, LCK, KIT, HBEGF, FYN, TRAT1, EGF, MBOAT7, KITLG]
GO:0048667;cell morphogenesis involved in neuron differentiation;6.0;0.811012628672052;0.7286266269261705;9.223059144383958;47.452274261266446;7.212124270218933;0.0015881849152503491;0.6919486831672181;[MEF2C, SLITRK6, SLC1A3]
GO:1903955;positive regulation of protein targeting to mitochondrion;10.0;0.9326813400603323;0.8815816818910864;9.597752593825367;662.5702871444865;6.311337724880743;0.022175631236180954;0.7380031166185408;[ABLIM3, RAC2, FZD5, RHOU]
GO:0002503;peptide antigen assembly with MHC class II protein complex;7.0;1.0;0.8509193652572005;9.628524252492122;45.61567929762514;8.67846133901236;0.0015267157346454312;0.7947362817240173;[HLA-DMA, HLA-DMB, HLA-DRA]
GO:0035767;endothelial cell chemotaxis;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;58.99646552848538;7.474488534686424;0.0019745586078665435;0.7572456912631272;[NR4A1, NRP1, EGR3, CXCL13]
GO:0015816;glycine transport;10.0;0.8436909121759173;0.837086467948879;9.466005322994347;184.47124825534323;7.474488534686424;0.006174086665761407;0.7974867031240476;[SLC36A1]
GO:0010248;establishment or maintenance of transmembrane electrochemical gradient;6.0;1.0;0.8231203125901445;9.628524252492122;27.942148572769092;7.212124270218933;9.351985664295021E-4;0.6919486831672181;[ATP1B2, ATP1B1]
GO:0032499;detection of peptidoglycan;6.0;0.9326813400603323;0.7894609826203107;9.571365838652174;162.92766460988707;9.083926447120524;0.005453042309114497;0.7876727335416686;[TREM2]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, CD80, CXCL13, PYCARD, EDNRB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, STAP1, NLRP3, S100A14, ELANE, ABCA1, JUN, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, CXCL10, CXCL11, IL6, ALPL, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, CXCL3, CXCL2, CXCL5, ALAD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, PTGIR, CHUK, ARG1, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, TLR4, CX3CR1, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, GCH1, CCL20, NR1H2, LILRB1, LILRB2, MAPK14, CD6, LTBR, PF4]
GO:0032497;detection of lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;150.00497270670016;8.390779266560578;0.005020531440782482;0.7522251544931926;[LY96, TREM2, TLR4]
GO:0015813;L-glutamate transmembrane transport;11.0;0.8653626801206646;0.8651102923899945;9.551563211355994;441.01685901872065;6.8867018697843045;0.014760437381951706;0.7846152062148197;[SLC1A3, SLC17A6, SLC7A11, SLC1A6]
GO:2000660;negative regulation of interleukin-1-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;306.2706419112467;8.16763571524637;0.010250602759086841;0.7926932703116032;[IL6, IL1R2]
GO:2000661;positive regulation of interleukin-1-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;305.68887294206377;9.777073627680469;0.01023113147524637;0.875;[IL1R1]
GO:0035524;proline transmembrane transport;11.0;0.8653626801206646;0.8651102923899945;9.584072489921288;330.9290371701472;7.9853141584524145;0.011075897057287277;0.8407982897480031;[SLC36A1]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[NRP1, PLXND1, LRRK2, MEN1, MEF2C, MMP9, LRP1, EPB41L5, CTHRC1, PLK2, CAV1, BMP2, RAN]
GO:1905065;positive regulation of vascular smooth muscle cell differentiation;8.0;0.8653626801206646;0.8076813400603323;9.488762310116963;295.7578040146463;7.9853141584524145;0.009898747535627478;0.7833693374183408;[MYOCD, KIT, ENG]
GO:0045445;myoblast differentiation;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;6.599019797332524;7.050676185779127E-4;0.587474179321389;[DTYMK, JAG1, MAPK14]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SLA2, GRAP2, AKT1, EPHB1, PDGFRB, PDGFRA, MAP2K2, VRK1, MELK, BTK, SIK1, BLK, CSF1R, LYN, BMX, EIF2S1, CLK4, PTK2, CLK1, ITK, LRRK2, MAP4K1, SYK, IRAK3, FGR, ZAP70, HCK, LCK, KIT, PAK1, FYN, CSK, CAMK4, TEK]
GO:0060603;mammary gland duct morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;32.20947323359611;8.16763571524637;0.0010780220824845236;0.7408135829017477;[CSF1R]
GO:0045446;endothelial cell differentiation;5.0;0.7866048967936545;0.6835434602577475;8.935377071932177;24.20171999872632;6.599019797332524;8.100097882234571E-4;0.6277151911823093;[TMEM100, JAG1, HOXB5]
GO:0150018;basal dendrite development;7.0;1.0;0.8509193652572005;9.628524252492122;34.02047363004817;9.777073627680469;0.0011386346359592329;0.8509193652572005;[NRP1]
GO:0050806;positive regulation of synaptic transmission;7.0;0.6729672293956388;0.6874029799550199;8.679443697794976;101.54719009341356;4.857092701852345;0.0033986930658887844;0.599311311907839;[FMR1, NRGN, TNR, KMO, ADCYAP1, SLC24A2, SLC24A1, NLGN1, SLC1A3, RETN, ADRB2, PTGS2, DRD4, PLK2]
GO:0048843;negative regulation of axon extension involved in axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;2931.023726508963;6.558197802812269;0.09809872637615838;0.7835068532133509;[NRP1, SEMA5B, SEMA4B]
GO:0048842;positive regulation of axon extension involved in axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;2927.4139206492227;7.8311634786251565;0.09797790942264722;0.8486063770733797;[NRP1, CXCL12]
GO:0060715;syncytiotrophoblast cell differentiation involved in labyrinthine layer development;5.0;1.0;0.7902410118609202;9.628524252492122;42.294635617598914;9.083926447120524;0.0014155633914202197;0.7547934328124444;[FZD5]
GO:0006930;substrate-dependent cell migration, cell extension;6.0;1.0;0.8231203125901445;9.628524252492122;58.56724312331254;7.474488534686424;0.001960192920240494;0.7053660038532718;[NRP1]
GO:0048846;axon extension involved in axon guidance;6.0;1.0;0.8231203125901445;9.628524252492122;104.6753254820163;7.697632086000634;0.003503388942206243;0.7167775754447168;[NRP1, NRP2, ALCAM]
GO:0045217;cell-cell junction maintenance;5.0;0.8653626801206646;0.7229223519212526;9.310070521373587;51.610367046990525;7.474488534686424;0.0017273525387479806;0.6724867031240476;[CSF1R, F2R, PRTN3, CD177]
GO:0060716;labyrinthine layer blood vessel development;5.0;1.0;0.7902410118609202;9.628524252492122;85.12843743852892;6.781341354126479;0.0028491721904478507;0.6370391240755715;[FZD5, AKT1, CYR61]
GO:0060718;chorionic trophoblast cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;8.16763571524637;7.050676185779127E-4;0.6676932703116032;[FZD5, E2F7]
GO:0050921;positive regulation of chemotaxis;6.0;0.6417349323569144;0.6439877787686017;8.362857879160845;97.3409382187974;4.886724499458715;0.003257913601026301;0.5730276307483924;[NRP1, CXCL6, CXCL9, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, C3AR1, RAC2, CCR7, CCR6, IL6R, CCR2, PDGFRB, IL1B, XCL1, SUCNR1, C5AR1, FPR2, PLA2G7, THBS1, CCL7, CCL5, PDGFD, CXCR2, CCL4, NTF3, CCL1, NCKAP1L, CCL19, S100A14, CCR1, TGFB1, TNFSF14, CCL21, AZU1, PPBP, MAPK14, CXCL10, CXCL11, IL6, CXCL12, PF4]
GO:0035589;G-protein coupled purinergic nucleotide receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;82.06132384088221;7.069023426578259;0.0027465186585576445;0.7365101867784198;[P2RY13, P2RY6, P2RY14, P2RY2, GPR87, PTAFR, GPR171]
GO:0060982;coronary artery morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;32.54494596988572;7.57984905034425;0.0010892500530622757;0.710754145523778;[NRP1, LRP2]
GO:0060627;regulation of vesicle-mediated transport;5.0;0.4849414530207067;0.5327117383712736;6.805163204878917;26.124861613659725;3.5745381104925467;8.743756073601922E-4;0.47304305706453076;[LGALS3, SLC11A1, ACTN4, SFRP4, EPHA3, CFTR, LLGL2, STXBP2, NCKAP1L, LYN, AZU1, SDC1, NRP1, RAC2, CD36, CCR2, ANXA1, FCER1G, SYK, RAB33B, HCK, CEACAM1, IL1B, GAS1, TLR2, PTAFR, GNAI2, NTF3, CCL19, CCL21, NR1H2, LILRB1, GOPC, FMR1, SIRPG, TNF, PYCARD, IL13RA2, CD177, MAP2K2, TSC2, HGS, PRTN3, CD151, CORO1A, STAP1, EVI5, TGFB1, SYT2, CAV1, SELE, TBCK, MCTP1, ITGAM, LRRK2, SIRPB1, TBC1D9, DNM2, FGR, IFNG, NLGN1, LRP1, DLL1, RAB21, CCL2, CSK, EGF, VPS41, PTX3, FCGR2B]
GO:0099054;presynapse assembly;4.0;1.0;0.75;9.628524252492122;34.5996765512564;7.474488534686424;0.0011580200364832854;0.6322456912631272;[NLGN4Y, FZD1, NLGN1]
GO:0043171;peptide catabolic process;6.0;0.7192862368539868;0.682763431017138;8.971744716103052;139.83704318034597;6.280566066213989;0.0046802199900778775;0.6443087532925187;[ENPEP, ACE, TRHDE, ANPEP, CTSH]
GO:0001569;branching involved in blood vessel morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.375876246018314;0.0017907488225476112;0.6769819729871445;[NRP1, PLXND1, SFRP2, COL4A1, ENG]
GO:0070306;lens fiber cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;24.20171999872632;7.212124270218933;8.100097882234571E-4;0.659069382437994;[TGFB1, SLC7A11]
GO:0015722;canalicular bile acid transport;10.0;1.0;0.9152410118609203;9.628524252492122;105.66982015532285;8.390779266560578;0.003536673783934714;0.8443458537639685;[ABCC3, AQP9]
GO:0015721;bile acid and bile salt transport;9.0;0.9326813400603323;0.8625812952104552;9.5544162803384;89.96332036720499;6.375876246018314;0.003010991370958501;0.722303232910233;[ABCC3, SLC10A2, AQP9, CEACAM1, SLCO2B1]
GO:0032060;bleb assembly;6.0;1.0;0.8231203125901445;9.628524252492122;58.56724312331254;7.474488534686424;0.001960192920240494;0.7053660038532718;[PMP22, EMP1, MYLK]
GO:0035333;Notch receptor processing, ligand-dependent;8.0;1.0;0.875;9.628524252492122;50.748517158788495;7.8311634786251565;0.0016985071986044009;0.7754860644832351;[PSEN2]
GO:2000350;positive regulation of CD40 signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;186.95064880168647;9.777073627680469;0.006257069970731893;0.8509193652572005;[TREM2]
GO:0034241;positive regulation of macrophage fusion;7.0;1.0;0.8509193652572005;9.628524252492122;142.40946411816813;8.67846133901236;0.0047663166038382455;0.7947362817240173;[ADAM9]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[TGFB1I1, GATA3, TNF, FOXO1, E2F1, TGFB1, JAG1, SORT1, SIRT1, IL6]
GO:1902946;protein localization to early endosome;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;33.466755985853425;8.67846133901236;0.001120102204721561;0.7947362817240173;[NRP1]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[PHB2, AKT1, PROK2, MEF2C, CLDN7, PRKCQ, GATA3, SLC30A10, FIGNL1, SFN, NCKAP1L, BARD1, JUN, PLK2, AZU1, CDKN1A, CHL1, TIMP1, ANXA1, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, PF4, TNF, CLEC5A, F2R, ADCYAP1, MSH2, CSF1R, BLM, CORO1A, FOXO1, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, CXCL12, COPS5, BCL6, MYD88, LRRK2, FASLG, CYR61, TNFRSF1B, ADAMTS20, CX3CR1, LRP1, NLRC4, CCL5, CCL2, FYN, TIE1, IL2RB, SLC46A2, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB1, FLT3LG, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, NRP1, BRCA1, CTSH, CCR7, CCR5, FCER1G, HCK, RNF144B, CEACAM6, IL1B, KIT, YAP1, IFI6, GNAI2, CXCR2, PDPN, LILRB1, CD40LG, GRINA, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, CBX4, CAV1, NR4A2, NFKBIA, IL6, NR4A3, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, MMP9, NDUFS3, LTF, BCL2A1, TAF9, DLL1, THBS1, HSPD1, TEK]
GO:0042098;T cell proliferation;6.0;0.7248374789738407;0.6855390520770648;9.081980546124052;51.294476028837884;6.343086423195323;0.0017167799506538708;0.647506047256038;[CD151, FYN, TNFSF14, SLC11A1, LILRB1]
GO:0070779;D-aspartate import across plasma membrane;11.0;1.0;0.9324289523296623;9.628524252492122;425.4525215124219;8.390779266560578;0.014239513012610231;0.8615337942327104;[SLC1A3]
